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1. INTRODUCTION
1.1 Notch receptors and ligands
In 1917, Thomas Hunt Morgan and colleagues described a strain of Drosophila with notches 
at the end of their wings (Morgan et al., 1917). This curious trait was attributed to a partial 
loss of function of what would later be identified as the Notch gene. The Notch gene, which 
was cloned in the mid-1980s by groups of Artavanis-Tsakonas (Wharton et al.,  1985) and 
Young (Kidd et al., 1986), encodes a type I transmembrane receptor. In  Drosophila only a 
single Notch protein and two ligands (Delta and Serrate) are present , while mammals, such as 
mice and humans, possess four Notch proteins Notch1–4 (Weinmaster et al., 1992, Lardelli et 
al.,  1994,  Uyttendaele  et  al.,  1996),  and  five  ligands,  named  Delta-like-1,-3  and  -4 
(DLL1,DLL3 and  DLL4)  (Radtke  et  al.,  2003)  and Jagged1,  Jagged2  (JAG1 and JAG2) 
which are Ser-like ligands (Figures 1a,1b) (Radtke et al.,2003). 
In mammals, the Notch receptor is produced as precursor that is modified in the secretory 
pathway. It is cleaved in two parts by Furin protease in the trans-Golgi and is exposed to the 
cell  surface as heterodimeric receptor (Blaumueller  et al.,  1997, Loegat  et  al.,  1996). The 
Notch  heterodimer  consists  of  noncovalently  associated  extracellular  and  transmembrane 
domains.  The  extracellular  domain  contains  the  signal  peptide  and 36  tandemly repeated 
copies  of  an  epidermal  growth  factor-like  motif  (EGF-like).  The  transmembrane  subunit 
contains  a short  extracellular  domain,  the membrane-spanning region,  and an intracellular 
domain  (termed  ICD)  containing  several  conserved  motifs.  Stable  association  of  the  two 
Notch subunits is dependent on a newly described heterodimerization domain comprising the 
carboxy-terminal end of the extracellular subunit and the extracellular amino-terminal end of 
the transmembrane subunit (Figure 1c) (Sanchez-Iriazzy et al., 2004).
The amino-terminal EGF-like repeats participate in ligand binding, whereas the LN repeats 
(present  in  the  extracellular  domain)  prevent  signalling  in  the  absence  of  ligand.  The 
cytoplasmic extension of Notch contains a RAM domain, six ankyrin (also known as CDC10) 
repeats,  two  nuclear-localization  signals,  a  transactivation  domain  (TAD)  and  a  PEST 
sequence (Figure 1c).  Although the structures of the four Notch receptors are  very similar, 
they show differences in the extracellular  and cytoplasmic parts.  The Notch1 and Notch2 
receptors contain 36 EGF repeats in their extracellular domain, whereas Notch3 harbours 34 
and Notch4 only 29 repeats (Bray et al., 2006). Additional differences are found within the 
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cytoplasmic domain; specifically, Notch1 contains a strong TAD, and Notch2 a weak TAD 
and  no  TAD  is  present  in  Notch3  and  Notch4,  however  all  the  four  receptors  have 
transactivation activity. The main structural differences between the ligand family members 
are the number and spacing of EGF-like repeats in the extracellular domain and the presence 
of a cysteine-rich domain (LN domain, which is located downstream ofthe EGF-like repeats) 
in Ser, JAG1 and JAG2 (Figure 1c). 
a                                                                                    b
                   c                         
             
Figure 1 Structure of Notch proteins and their ligands
a) Scheme of Notch receotors. Notch receptors (Notch1-4) are presented on the cell surface as heterodimers.  b) Scheme of 
Notch ligands.  Two transmembrane-bound ligands for  Notch have been identified in Drosophila,  named Delta (Dl) and 
Serrate  (Ser).  The  vertebrates  possess  three  Delta  homologues,  called  Delta-like  (DLL)-1,  -3  and  -4,  and  two  Serrate 
homologues, Jagged 1 (JAG1) and Jagged 2 (JAG2). Serrate, Jagged1 and Jagged2 harbour a cysteine-rich domain (CR) 
following the EGF-like repeats. c) Domain structure of the eterodimer Notch receptors. The ectodomain of Notch receptors 
contains EGF-like repeats and a cysteine-rich Notch/Lin12 domain (LN); this is followed by a transmembrane domain, the 
RAM domain  and six  ankyrin  repeats  (ANK),  two  nuclear-localization  signals  (NLSs),  followed  by the  transactivation 
domain (TAD) and a PEST sequence. Adapted from Radtke et al., 2003.
1.1.1 The Notch pathway
Notch signaling is initiated by a receptor-ligand interaction between two neighbouring cells, 
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notably the ligand is expressed in the signaling sending cell while the receptor in the signaling 
receiving cell. This cell–cell contact is an important prerequisite to trigger the signalling event 
leading to two successive proteolytic cleavages, that liberate the cytoplasmic portion of Notch 
(NICD) from the membrane in the receiving cell. 
The  first  cleavage,  caused  by  an  ADAM  disintegrin  and  metalloprotease  occurs  on  the 
transmembrane  subunit  close  to  the  transmembrane  domain  outside  the  cell  (Bray  et  al., 
2006). The second occurs within the transmembrane domain of Notch and is induced by  a 
multisubunit protease called gamma secretase that contains presenilin, nicastrin, PEN2 and 
APH1 (Figure 2) (Fortini et al., 2002, De Strooper et al., 1999). The second cleavage releases 
the Notch intracellular domain (NICD), which then translocates to the nucleus and cooperates 
with  the  DNA-binding  protein  CSL (named  after  CBF1,  Su(H)  and  LAG-1)  and  its  co-
activator  Mastermind (Mam) to promote transcription.  In the absence of Notch signalling, 
CSL  binds  to  the  promoters  of  its  target  genes  and  recruits  corepressors  and  histone 
deacetylases,  which  inhibit  transcription  (Kao  et  al.,  1998).  When  NICD  is  present,  it 
competes with the inhibitory proteins for CSL binding. It then recruits co-activators including 
Mastermind  and  histone  acetyltransferases, which  convert  CSL  from  a  transcriptional 
repressor to a transcriptional activator (Bray et al., 2006, Fryer et al., 2002) (Figure 2). 
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Figure 2. The Notch pathway
Notch proteins are synthesized as precursor proteins that are processed by a furin-like convertase in the Golgi (1) before 
being transported to the cell surface, where they reside as heterodimers. 2) Interaction of Notch receptors with their ligands, 
such as Delta-like or Jagged (2), leads to a cascade of proteolytic cleavages. The first cleavage is mediated by TACE (3), 
followed  by  a  second  cleavage  mediated  by  the  gamma-secretase  activity  of  presenilins  (PS,4),  which  liberates  the 
cytoplasmic  domain  —Notch  intracellular  domain  (NICD).  The  liberated  NICD  enters  the  nucleus  and  binds  to  the 
transcription factor CSL, which displaces co-repressors (CoR) and recruits co-activators (CoA), leading to transcriptional 
activation of downstream target genes (5). Adapted from Radtke et al., 2003.
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1.1.2 Regulation of Notch-ligand activity 
Expression  of  Notch  ligands  during  development  is  quite  dynamic  and  contributes 
significantly  to  differential  activity  of  the  pathway.  In  some  developmental  contexts,  the 
ligand is produced by a distinct population of  cells. However, under many circumstances, 
differential  ligand  transcription  is  not  sufficient  to  explain  why certain  cells  become  the 
signal-sending cells. Indeed not only post-transcriptional modification of the receptors, but 
also  of  the  ligands  were  found  to  be  important  in  Notch  pathway.  The  most  important 
mechanism seems to  rely on ubiquitination. Indeed two E3 ubiquitin ligase were identified, 
Neuralized (Neur) and Mind bomb (Mib), that interact directly with Notch ligands and are 
required for ligand activation (Figure 3) (Le Borgne et al., 2005). 
Loss of Neur in  Drosophila melanogaster or  Xenopus leavis and of Mib1 in  Danio rerio 
results in neurogenic phenotypes (Le Borgne et al., 2005), typical for loss of Notch function. 
In normal cells, the extensive trafficking of Notch ligands is compromised in the absence of 
Neur or Mib, as  ligands accumulate at the cell surface but are inactive (Le Borgne et al., 
2005b). 
This observation indicates that regulation of  ligand activity by Neur and Mib is intimately 
associated with endocytosis and it requires the ubiquitin binding protein Epsin (Wang et al., 
2005).  Different  models  have  been  proposed  to  explain  the  link  between  ubiquitylation, 
endocytosis and ligand  activity (Le Borgne et al., 2005). For example, ligand endocytosis 
could  generate a ‘pulling force’ on a bound receptor that causes  a conformational change in 
the   Notch  heterodimerization  region  (Parks  et  al.,  2000).  Another  possibility  is  that 
ubiquitylation  promotes  ligand  clustering.  Indeed,  Notch  activation  is  more  effective   if 
ligands are clustered through fusion to an  Fc moiety or through immobilization on plastic 
(Varnum-Finney et al., 2000). A third possibility is that ubiquitylation permits trafficking into 
an endocytic compartment, which enables ligand  modification or results in re-insertion of the 
ligand into  specific membrane domains. Two observations support  this model. Segregation 
of RAB11, a component of the  recycling endosome or mutations in an exocyst component 
SEC15,  influence  signalling  in  the  Drosophila sensory  organ  precursors  (SOP),  a  well 
establish system to study Notch pathway (Emery et al., 2005). Whatever the mechanism for 
ligand activation, regulation of E3 ligases represents a crucial step for controlling the activity 
of the Notch  pathway. 
The localization of ligands within  the cell is important for effective signalling and might be 
influenced  by  other  proteins.  For  example,  Echinoid,  an  immunoglobulin  C2-type  cell-
adhesion molecule, colocalizes with Notch and Delta at adherens junctions in  Drosophila. 
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Genetic interactions indicate that Echinoid functions as a positive regulator to promote Notch 
signalling (Escuder et al., 2003). Echinoid colocalizes with Delta in endocytic vesicles, and 
Echinoid-mediated  adhesion  could  favour  Notch–Delta  interactions.  Consistent  with  this 
notion, it  has been shown that altered cyto-architecture of cells can affect  their signalling 
potential. 
Furthermore,  the  intracellular   domains  of  some  Notch  ligands  contain  protein–protein 
interaction motifs (for example, PDZ-binding motifs) that can bind to intracellular scaffolding 
proteins (Wrigth et al., 2004). 
Structurally, the  ligands share many characteristics with Notch itself and are prone to similar 
modifications  including  proteolytic  processing  (Mishra-Gorur  et  al.,  2002).  However,  the 
purpose of ligand cleavage remains unclear. One hypothesis is  that proteolytic processing of 
the ligand contributes to ligand downregulation (Mishra-Gorur et al., 2002). For example, loss 
of  the  metalloprotease  Kuzbanian-like,  which  has  been  shown to cleave  Delta,  results  in 
ectopic Notch signalling in certain locations. Another hypothesis is that cleaved or secreted 
ligands  antagonize  Notch  signalling,  because,  under  most  circumstances,  soluble  ligand 
fragments  inhibit   receptor  signalling  (Le  Borgne  et  al.,  2005).  It  is  also   possible  that 
cleavage of transmembrane ligands could transmit an intracellular  signal through activities 
that are  associated with the ligand’s intracellular domains. Further investigations are needed 
to identify all of the functional consequences of ligand  proteolysis on Notch signalling in 
vivo.
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Figure 3. Ligand activation entails ubiquitylation
The E3 ubiquitin ligases  Neuralized (Neur) and Mind bomb (Mib) interact  directly with  Notch ligands.  LEFT,  inactive 
ligand: Prior to modification by Neur or Mib, ligands are inactive, and can be endocytosed and degraded. Neur- or Mib-
mediated ubiquitylation (Ub) of Notch ligands is required for Epsin-mediated endocytosis. RIGHT, active ligand: Ligands are 
then competent to signal either because endocytosis is directly associated with receptor activation or because it allows entry 
into a specific compartment or membrane domain that renders ligands active. They can also be targeted for degradation. E2,  
ubiquitin-conjugating enzyme.  Adapted from Bray et al., 2006.       
1.1.3 Notch-receptor maturation
Notch  receptors  have  broad  expression  patterns  in  many  tissues,  but  analyses  of  where 
cleavage  occurs  or  where  target  genes  are  expressed  reveal  a  well-regulated  profile  of 
activation. These observations indicate that the activity of the receptor must also be regulated 
through post-transcriptional mechanisms. 
Notch proteins have a large  extracellular domain that consists of multiple EGF-like repeats, 
which are sites  for glycosylation (Haines et al., 2003). The enzyme O-fucosyl transferase (O-
Fut) adds the first fucose and is essential for the generation of a functional receptor (Okajima 
et al., 2005). Indeed depletion of O-Fut in  Drosophila and mice results in phenotypes that 
resemble those associated with lack-of-Notch signalling. Not only is the  enzymatic activity 
important, O-Fut also functions as a  chaperone to promote the folding and transport of Notch 
from the endoplasmic reticulum to the cell membrane (Okajima et al., 2005). Multiple  EGF 
repeats  in  Notch  have  the  potential  to  be  modified   and,  therefore,  a  large  repertoire  of 
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differentially modified receptors could be generated. It has been shown that these glycosyl-
modifications alter the capability of ligands to activate Notch. For example, in dorsal cells of 
the  Drosophila wing,  the  glycosil  transferase  Fringe  potentiates  activation   by Delta  and 
renders  Notch  resistant  to  activation  by  Serrate.  For  example,  Serrate  binds  with  higher 
affinity to Notch fragments that have  been fucosylated and with lower affinity to fragments 
that have been further modified by Fringe (Okajima et al., 2003). 
Mutation of the glycosylation site in EGF-repeat  12,  a crucial  repeat   for ligand binding, 
allows activation of Notch by Serrate  even in the presence of Fringe, which indicates that this 
is a key site for modification (Yang et al., 2005). Furthermore, Lunatic Fringe, a mammalian 
homologue  of  Fringe,  potentiates  Delta  binding  in  in  vitro  studies  and  promotes  Notch 
activity.  These  observations  indicate  that  glycosylation  patterns  might  do  more  than 
producing an all-or-none effect on different ligands. 
1.1.4 Proteolytic cleavage of Notch
Notch signaling is initiated by a receptor-ligand interaction that triggers the signalling event 
leading to  two successive proteolytic  cleavages.  The first  cleavage,  caused by an ADAM 
disintegrin  and  metalloprotease  occurs  on  the  transmembrane  subunit  close  to  the 
transmembrane domain on the outside of the cell  (Bray et al., 2006). Two metalloproteases 
have been implicated in the S2 cleavage,  ADAM10 (also known as Kuzbanian; Kuz) and 
tumour-necrosis factor-alfa (TNFalfa)-converting enzyme TACE, also  known as ADAM17, 
that have partially redundant roles (Fortini et al., 2002, Brou et al., 2000). The S2 protease 
cleavage  remains  an  important  aspect  for  investigation,  particularly  because  studies  of 
metalloproteases  reveal  the  potential  for  regulation  by  external  factors,  membrane 
environment and intracellular signalling pathways. 
The  S3  cleavage  occurs  within  the  transmembrane  domain  of  Notch  and  is  induced  by 
gamma-secretase, an enzymatic complex that contains presenilin,  nicastrin, PEN2 and that 
liberate the cytoplasmic portion of Notch (NICD) from the membrane in the receiving cell. 
Presenilins (PS1 and PS2) are required for intramembrane cleavage of an increasing number 
of type I membrane proteins, including the amyloid precursor protein of Alzheimer's disease 
(Xia et al., 2003). Moreover, regulated intramembrane proteolysis is a novel mechanism 
involving proteases that hydrolyze their substrates in a hydrophobic environment. Genetic and 
biochemical studies have implicated the proteolytic processing events that lead to amyloid-
beta-peptide generation in the pathogenesis of Alzheimer's disease. Mutations in APP and the 
presenilins (PS1 and PS2) cause familial early-onset Alzheimer's disease, and presenilin 
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mutations lead to increased processing of APP by gamma-secretase in vitro and in 
vivo(Lendon et al., 1997). 
PS1-deficient mice show developmental abnormalities consistent with altered Notch 
signalling (Wong et al., 1997, Shen et al., 1997) and genetic interactions between the notch 
homologues glp-1 and lin-12 and the presenilin homologues sel-12 and hop-1 in C. elegans 
provide indirect evidence for the involvement of the presenilins in the Notch signalling 
pathway (Levitan et al., 1995, Levitan et al., 1998). Furthermore, PS1-deficient mice and 
PS-1/PS-2 double knockout mice had a marked decrease in NICD generation. (De Strooper et 
al., 1999).
Mutagenesis, affinity labeling,  biochemical isolation,  and reconstitution in cells reveal that 
PS, in complex with co-factors nicastrin, APH-1 and PEN-2, apparently contains the active 
site of gamma-secretase, a membrane aspartyl protease (Figure 5). 
PS contains  YD and LGXGD motifs  in two transmembrane domains that is postulated to 
constitute an aspartyl protease active site. PS1 and PS2 are 467 and 448-residue polypeptides, 
respectively, and share ~60% sequence similarity. Full-length PS undergoes endoproteolysis 
to form stable N-terminal (NTF) and C-terminal (CTF) fragments, which remain associated 
and establish  the  active  form of  the  enzyme  (Xia  et  al.,  2003).  Investigation  of  the  PS-
containing  high-molecular-weight  (HMW)  complex  indicates  that  additional  cofactors 
intimately associate with PS to form the active gamma-secretase complex. In common with 
anti-PS1 antibodies, anti-nicastrin antibodies can precipitate the functional gamma-secretase 
complex (Elser et al., 2002) and although glycosylation of nicastrin is not absolutely required 
for  gamma-secretase  activity,  mainly  the  mature  form  of  nicastrin  (glycosilated)  was 
identified  in the HMW gamma-secretase  complex,  and levels  of  nicastrin  in cells  closely 
correlate with PS levels  (Xia et al.,  2003). Reduction of PS levels  leads to a concomitant 
reduction in nicastrin levels, and downregulation of nicastrin expression decreases the levels 
of stabilized PS molecules.
Interestingly, one of the emerging approaches for blocking Notch signaling is suppression of 
cleavage by gamma-secretase to prevent generation of the oncogenic NICD and suppress the 
Notch
 
activity. 
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Figure 5. Schematic representation of the components of the gamma-secretase complex 
and Notch1 cleavage
Schematic rappresentation of the transmembrane domains of Presenilin-1 (PS). In yellow the two aspartyl residues, present in 
NFT and CTF. Nicastrin (Nct), APH1 and PEN2 are shown in yellow, baby blue and red respectivly. Gamma seretase site of 
cleavage is indicated by the red arrow.
1.1.5 Notch endocytosis and trafficking
Endocytosis  is  used  by  eukaryotic  cells  to  regulate  nutrient  internalization,  signal 
transduction, and the composition of the plasma membrane. However, a more complex picture 
is emerging, in which endocytic pathways integrate various signals, thereby contributing to a 
higher  level  of  cellular  and  organismal  organization.  In  this  way,  endocytosis  and  cell 
signaling are intertwined in many biological  processes,  such as cell  motility and cell  fate 
determination (Polo et a., 2006).  Notch is a cell-surface receptor, so its expected location is 
the plasma membrane. However, a substantial amount of Notch is targeted for degradation 
and a large fraction of Notch is detected in the cytoplasm in compartments of the  endocytic 
pathway. Studies in Drosophila have  shown that Notch colocalizes with the RAB GTPases 
RAB5  and  RAB7,  which  are  both  markers  of  the  endocytic  pathway.  Moreover,  Notch 
accumulates in  intracellular structures when the endocytic progression is perturbed (Wilkin et 
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al., 2004). 
Entry into the endosomal and multivesicular-body-sorting pathway is thought to be intimately 
linked with ubiquitylation of transmembrane proteins. Several E3 ligases that  target Notch 
have been identified. The Itch/Su(dx) family of HECT domain E3 ligases are predominantly 
negative regulators of Notch signalling,  by targeting Notch for its degradation. A second E3 
ligase that binds to Notch, within the  ankyrin repeats, is the RING finger protein Deltex (Le 
Borgne et al., 2005). Intriguingly, in several mammalian cells, including lymphoid cells and 
neurons,  Deltex  antagonizes  Notch.  Perhaps  the  precise  balance  of  different  E3-ligase 
activities  dictates  the  outcome  on  Notch  localization  and  activity.  These  ubiquitin 
modifications could potentially influence the duration of the receptor is located on the surface, 
its  accessibility to ligands, or its capability to interact with  gamma-secretase. It is evident 
that Notch is subject to different types  of post-transcriptional regulation. 
The activity of Numb, a well characterized Notch inhibitor, also involves endocytosis. Numb 
is asymmetrically segregated into one of two daughter cells in several lineages, and a search 
for  mutants  giving  Numb-related  phenotypes  identified  α-adaptin,  a  component   of  the 
adaptor protein-2 (AP2) complex that links cargoes to clathrin  coats  of transport vesicles. 
Numb  interacts  with  α-adaptin  and  with  Notch,  so  it  could  directly  recruit  Notch  into 
endocytic vesicles. Furthermore, mammalian Numb promotes Notch ubiquitylation (McGill et 
al., 2003). However, partial rescue of Numb phenotype is observed with Numb proteins that 
lack  the  α-adapt  ininteraction  domain,  which  is  indicative  of  alternative  mechanisms  of 
Numb-mediated antagonism. 
Recently  it  was  demostrated,  that  a  monoubiquitination  event  takes  place  on the NdeltaE 
molecule,  a constitutively active form of the Notch receptor  that  mimics  the intermediate 
TACE-processing  product  generated  after  ligand  binding(Gupta-Rossi  et  al.,  2004).  This 
modification is a prerequisite for gamma-secretase cleavage of NdeltaE. The major site of 
monoubiquitination was localized to a conserved lysine residue K1749 in mouse Notch1. It 
was proposed that this ubiquitination step and endocytosis are required in the context of the 
full-length receptor for its gamma secretase-dependent cleavage.
Glycosylation and proteolytic processing steps have a crucial influence on  receptor activity, 
and  are  potentially  important  steps  for  drug  intervention.  Ubiquitylation  and  endocytic 
trafficking can modulate  the amount  of receptor that  is available  for signalling and could 
therefore provide powerful  mechanisms to tune the activity of the pathway.
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Figure 4 . Processing and trafficking regulate Notch-receptor activity
Notch maturation. Notch (purple) is produced in the endoplasmic reticulum where it interacts with the O-fucosyl transferase 
(O-Fut; green, 1) and is transported to the Golgi. In the Golgi, it is processed by Furin-like convertase (grey, S1 cleavage, 2) 
and glycosylated (shown as dark grey protrusion from Notch) by O-Fut and other glycosyltransferases (for example, Fringe) 
before export to the cell surface. Notch that is endocytosed from the cell surface can be recycled or degraded through the 
multivesicular-body  pathway  (3).  Actions  of  the  ubiquitin  ligases  Deltex  and  Itch/NEDD4/Su(dx)  regulate  trafficking, 
although  their  precise  roles  are  not  yet  clear.  Other  proteins  (syntaxin,  ESCRT complexes)  that  affect  trafficking  are 
indicated, but their sites of action are hypothetical and remain to be fully clarified. Ub, ubiquitin.
Adapted from Bray et al., 2006.
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1.1.6 Notch nuclear activity 
Following Notch activation, N1ICD enters the nucleus and directly regulates the expression of 
target genes. Among the Notch targets, the best characterized are the bHLH  (basic-helix–
loop–helix) genes of the E(spl)/HES class and recently several new N1ICD targets have been 
identified: cyclin D1, NF-kB, PPAR, myc, p21Waf1/Cip1 (Bray et al., 2006) .
N1ICD enters the nucleus and binds the transriptional factor CSL. This DNA binding protein 
is the essential effector of the Notch transcriptional activity and has been highly conserved 
throughout evolution (84% identity between human and Drosophila proteins). 
In the absence of Notch activity, CSL proteins recruit co-repressors. In mammalian cells, CSL 
co-repressors include SMRT and SHARP (Kao et al., 1998), which in turn recruit CtBP or 
other  global   co-repressors.  Two  other  CSL-interacting  proteins,  SKIP  and  CIR  (CBF1-
interacting  co-repressor),  are  also  part  of  the  repression  complex.  Homologues  of  these 
mammalian proteins exist in Drosophila  and have been linked with CSL or Notch signalling. 
In mice and Drosophila, the phenotypes that are  produced by depleting the single CSL are 
similar  but  not  identical  to  loss-of-Notch  function.  Initially,  these  differences  led  to  the 
speculation about CSL-independent Notch signalling. 
The precise mechanisms that are involved in Notch-dependent transcription are not known 
yet,  although  studies  in  mammalian  cells  have  revealed  a  number  of  recruited  cofactors. 
N1ICD forms a trimeric complex with  CSL and the co-activator Mastermind (Mam), which 
is  essential  for  N1ICD-dependent  transcription  in  vitro  and in  vivo (Wilson  et  al.,  2006) 
(Figure  6).  Although  Mam  binds  with  high  affinity  to  the  CSL/NICD  complex  in  an 
interaction that requires the ANK domain of NICD, neither NICD nor CSL bind to Mam 
separately  (Nam  et  al.,  2006).  The  structure  of  the  complex,  resolved  by  X-ray 
crystallography, explains why both CSL and the ANK domain of NICD are required for Mam 
binding. The interface between the two proteins forms an extended groove made up of the 
ANK domain of NICD on one side and the C-terminal domain (CTD) of CSL on the other. 
Mam is  nestled  within  this  groove  as  a  long helix,  making  extensive  contacts  with  both 
proteins.  Mam in  turn  recruits  the  histone  acetylase  p300,  which  promotes  assembly  of 
initiation and elongation  complexes (Wallberg et al., 2002). 
Immediately C terminal to the ANK of N1ICD there is a stretch of ~100 amino acids that has 
been  implicated  in  functional  interaction  with  cytokine-signaling  pathways  (Biga  set  al., 
1998), which is followed by a second functional nuclear localization sequence. Amino acids 
2155 to  2374 encompass  a transcriptional  activation  domain (TAD) followed by an OPA 
sequence.  The  C-terminal  TAD  of  N1ICD  has  been  shown  to  associate  with  the 
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transcriptional coactivators PCAF and GCN5 (Kurooka et al., 2000), but this domain alone is 
not sufficent for the N1ICD transcriptional activity.
The emerging picture is that Notch signalling requires recruitment of histone acetyltransferase 
complexes and  exchange of histone variants to activate transcription. In addition, BRE1, a 
homologue of the yeast histone 2B  ubiquitin ligase, is crucial for Notch function in vivo and 
stimulates Notch-dependent transcription in a transient transfection assay (Bray et al., 2005). 
Together the data show that Notch activity is highly sensitive to  chromatin modifications and 
histone re-arrangements  that could contribute to target-gene specificity. 
Furthermore, overexpression of two Polycomb group  epigenetic silencers enhances Notch-
induced hyperproliferation and also causes hypermethylation of the tumour suppressor gene 
Rb, indicating  further  mechanisms  that  could constrain the accessibility  of  enhancers  and 
cooperate with Notch to confer different programmes of gene expression (Ferres-Marco et al., 
2006). 
Therefore, binding of tissue-specific activators contributes to robust target-gene expression, 
and can explain the specificity of Notch responses in different cell types.  
The assembly of the co-activator complex not only  promotes transcription, but also results in 
turnover  of  N1ICD.  This  is  achieved  by recruitment  of  factors  such  as  cyclin-dependent 
kinase-8 (CDK8), which  phosphorylates N1ICD, rendering it into a substrate for the nuclear 
ubiquitin  ligase  FBW7 (Fryer  et  al.,  2004,  Thompson et  al.,  2007).  In  mammalian  cells, 
FBW7 preferentially interacts with a phosphorylated form of N1ICD and the expression of a 
dominant negative FBW7 leads to increased expression  of Notch targets (Thompson et al., 
2007, Wu et al., 2001). This interaction requires the  C-terminal PEST region, consistent with 
observations that Notch with C-terminal truncations are very stable, and in humans contribute 
to oncogenicity (Thompson et al., 2007). Degradation of N1ICD result in the dissociation of 
Mam and other co-activators, but it is unclear whether CSL proteins would also be affected or 
whether they remain intact on the DNA. 
Recently another kinase has been found to modulate Notch1 turn-over. Genetic studies have 
shown that the Drosophila homolog of glycogen synthase kinase-3beta (GSK3-beta), Shaggy, 
may act as a positive modulator of the Notch signaling (Ruel et  al.,  1993, Ramain et al., 
2001).  GSK3-beta is  a  serine/threonine  kinase  and  is  a  component  of  the Wnt/wingless 
signaling cascade (Kim et al., 2000). It was observed that GSK3-beta was able to bind and 
phosphorylate N1ICD  in  vitro,  and  attenuation  of  GSK3-beta activity reduced 
phosphorylation  of  N1ICD  in  vivo  (Foltz  et  al.,  2002).  Functionally,  ligand-activated 
signaling through the endogenous Notch1 receptor was reduced in GSK3-beta null fibroblasts, 
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implying a positive role for GSK3-beta mammalian Notch signaling. These studies reveal that 
GSK3 modulates  Notch1  signaling,  possibly  through  direct phosphorylation  of  the 
intracellular domain of Notch, and that the activity of GSK3-beta protects the intracellular 
domain from proteasome degradation.
                      
Figure 6. Model for Notch-activation of the HES1 gene. 
The proteins bound to the promoter prior to signaling are indicated in light colors (CBF1, RNAPII, CBP/p300, CDK7, and 
Spt6), whereas proteins that are recruited together with the NICD are shown in darker colors (MAM, SKIP, Med220, CDK8, 
CDK9/P-TEFb,  FACT).  Binding  of  MAM  to  p300  and  CycC:CDK8  can  promote  phosphorylation  of  p300, 
hyperphosphorylation of the NICD PEST domain (open circles), and facilitate Fbw7-mediated ubiquitination of the NICD to 
disassemble the Notch enhancer complex. Adapted from  Fryer et al., 2004.
1.2 Notch functions
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The Notch pathway functions during diverse developmental and physiological processes, can 
broadly be subdivided into three categories: 
Bynary cell-fate decision, Differentiation and Stem-cell maintenance (Figure 7).
                           
Figure 7. Notch signalling has pleiotropic effects in many different organs. 
Three main effects  are represented schematically. a) Notch signalling influences binary cell-fate decisions via lateral  or 
inductive signalling. In lateral signalling, two equipotent cells that initially express equal amounts of ligand (L) and Notch 
(N) gradually express either the ligand or Notch.  The Notch-expressing cell  receives  activation signals from the ligand-
presenting neighbouring cell, resulting in these two cells adopting very different fates. Inductive signalling occurs between 
two different cell types. A bi-potential precursor cell is instructed to adopt a particular cell fate (for example, cell fate A) after 
interacting with a distinct neighbouring cell expressing Notch ligands. In the absence of this Notch signal, the precursor cell 
would adopt another fate (for example, cell fate B) by default.  b) A Second property of Notch is its ability to influence 
differentiation and cell-cycle progression. Notch signalling between two developmentally related cells can initiate terminal 
differentiation processes and induce cells to exit the cell cycle.  c) Notch signalling can maintain stem cells or precursor 
populations in an undifferentiated state. (Adapted from  Radtke et al., 2003).
1.2.1 Bynary cell-fate decision
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Bynary cell-fate decision during neurogenesis in flies and vertebrates was the first function of 
Notch to be well characterized (Artavanis-Tsakonas et al., 1999). This is most apparent during 
the development of neuronal-precursor cells of the sensory organs (SOP, Drosophila), which 
originate  from a  group  of  equipotent  cells  that  have  the  capacity  to  develop  into  either 
neuronal-precursor cells or epidermal cells. Initially, the precursor cells express Notch and its 
ligand, but the concentrations of these proteins start  to differ  between neighbouring cells. 
Small differences in receptor and/or ligand concentrations are amplified over time, leading to 
cells that exclusively express either Notch or its ligand. The cell that receives Notch signals is 
inhibited from pursuing the path that leads to neuronal development and adopts an epidermal-
cell fate, whereas cells that exclusively express ligands are driven into the neuronal-cell fate, a 
process called Latheral Inhibition (Kimble et al., 1997). 
Another protein involved in SOP fate is Numb. The Numb loss-of-function phenotype is, in 
many  respects,  opposite  to  that  associated  with  the  loss  of  Notch.  At  each  asymmetric 
division, there is a differential level of Notch signaling between the two daughter cells that is 
opposite to the Numb levels. This different segregation leads to the different fates of the two 
cells. Experiments in which double mutants of  Notch and numb were generated place  numb 
genetically upstream of Notch. The contrasting phenotypes of Notch and numb, together with 
the discovery that the proteins can bind to each other directly, implied that Numb dictates the 
fate of SOP progeny by negatively regulating Notch (Guo et al., 1996).
Notch signalling can also occur between two deveopmentally distinct  cells   referred to as 
inductive cell-fate determination (Artavanis-Tsakonas et al., 1999). In this case, Notch and its 
ligands are expressed exclusively on two different cell types. The cell expressing the receptor, 
and therefore the recipient of the Notch signal, is induced to differentiate into a particular cell 
lineage. For example, a bipotential mouse neural-crest stem cell can be induced by Notch to 
adopt a glial-cell fate as opposed to a neuronal one by Notch ligands expressed on neuroblasts 
(Morrison et al., 2000). 
Mouse  thymic  epithelial  cells  expressing  ligands  for  Notch1  induce  early  lymphocyte 
precursors to adopt the T-cell fate as soon as they enter the thymus, whereas in the absence of 
Notch1 signalling these precursors adopt the B-cell fate as the default  pathway (Inductive 
cell-fate determination) (Osborne et al., 2007).
1.2.2 Differentiation
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Besides influencing the choice between two possible cell fates, Notch signalling can induce or 
enhance terminal  differentiation.  Notch signalling in epidermal stem cells thus differs 
from  other  progenitor  cell  populations  in  promoting,  rather  than  suppressing, 
differentiation  .In  human  skin,  Notch  signalling  initiates  a  terminal  differentiation 
programme  (Lowell  et  al.,  2000).  In  the  adult  mouse  skin  and  keratinocytes  this 
differentiation programme is triggered by Jagged-mediated Notch signalling, which induces 
early  differentiation  markers  and  cell-cycle  arrest  by  upregulating  p21WAF1/Cip1 
(Rangarajan  et  al.,  2001).  Interestingly  in  others  tissues  Notch  signaling  inhibits 
differentiation such as during maintainance of stem cells in instestine and brain.
1.2.3 Role of Notch in Embryonic Development 
Mutations have been introduced in mice for each of the four  Notch genes (Notch1–Notch4) 
and  four  Notch  ligand  genes  (Delta-like1,  Delta-like4,  Jagged1,  and  Jagged2).  Mice, 
homozygously disrupted with either  Notch1 (Molofsky et al., 2004, Swiatek et al., 1994) or 
Notch2 (Conlon et al., 1995, Hamada et al., 1999) are fatal at approximately embryonic day 
11  .  Notch3-null  (Krebs  et  al.,  2003)  and  Notch4-null  mice  (Krebs  et  al.,  2000)  survive 
without  any  apparent  phenotypic  abnormalities.  Homozygous  inactivation  of  Delta-like1, 
Delta-like4, or Jagged1 causes embryonic lethality during E9.5–E12.5 (73), and Jagged2-null 
mice die perinatally (Hrabe et al., 1997). These findings indicate that most of the individual 
Notch and ligand genes have non redundant roles in mouse embryogenesis. Somitogenesis, 
abnormal  vasculature  formation,  increased  cellular  apoptosis,  excessive  neuronal 
differentiation, etc., are observed in these mutant mice. There are, however, both similar and 
dissimilar phenotypes in these mice, and the causes of fatality in early to midgestation stages 
are not likely to be uniform in the knockout mice for each gene. On the other hand, successful 
progression to midgestation stages implies that Notch signaling is unnecessary for the very 
early stage of embryogenesis, including the fertilized egg stage (Jiang et al., 1998). This is 
consistent with the fact that activation of Notch signaling in Embryonic Stem Cells (ESCs), 
which are derived from the inner cell mass, does not block differentiation of ESCs (Shi et al., 
2005). 
However a predominat role of Notch pathway activity has been observed in regulating stem 
cell of mammary gland, central nervous system, vessels, hematopoietic system, intestine and 
muscle. 
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1.2.4 Notch Role in the Central Nervous System During Embryogenesis 
Among undifferentiated  neuroectodermal  cells  with  the  same  potential  during  Drosophila 
embryogenesis, some cells will eventually express Delta at higher levels, which sends a signal 
to surrounding cells that uniformly express the Notch receptor. Cells receiving the signal are 
blocked  from  differentiating  to  neuroglioblasts  (NGBs)  and  eventually  assume  another 
differentiation fate.  On the other hand, cells  that  express Delta differentiate  to NGBs and 
subsequently  to  neurons  and glial  cells.  Accordingly,  insufficient  levels  of  Notch  signals 
result in the “neurogenic phenotype,” in which all cells with neuronal potential differentiate 
into neurons. 
A conditional Notch1 knockout study (Scmitt et al., 2004) provides further support that Notch 
signaling inhibits the premature onset of neurogenesis. These studies, as well as those of CSL 
knockout  mice  (Lutolf  et  al.,  2002,  Hitoshi  et  al.,  2002),  suggest  that,  in  addition  to  the 
differentiation blockade, this pathway is required for the maintenance and expansion of the 
neural stem/progenitor cell pool. Inactivation of HES1 and HES5  in mice variably induces 
precocious  neuronal  differentiation  accompanied  by  a  decrease  in  neural  progenitors. 
Together,  these  studies  indicate  that  HES genes  are  the  conserved targets  of  Notch-CSL 
signaling for regulating the expansion and differentiation of neural progenitors.  
Importantly, Notch signaling either promotes or, by default, facilitates glial cell fate, perhaps 
as a consequence of inhibiting neuronal cell fate (Morrison et al., 2000). Therefore, Notch 
signaling might act on neural stem cells in two steps: (a) initially inhibiting neuronal fate 
while allowing for glial cell fate; and (b) then promoting differentiation to astrocytes while 
inhibiting differentiation to both neurons and oligodendrocytes. 
1.2.5 Notch role in Vasculature Formation 
Mice with disrupted Notch receptors display various abnormalities in blood vessel formation, 
such  as  proliferation  and  migration  of  endothelial  cells,  smooth  muscle  differentiation, 
vascular remodeling processes, and arterial-venous identification. These studies describe the 
involvement of Notch1 (Krebs et al., 2000), Notch3, and Notch4 receptors and Delta-like4 
(Krebs et al., 2004) and Jagged1 ligands in vasculature formation. 
1.2.6 Stem cell functions 
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In  mammals,  a  wide  variety  of  cells  use  the  Notch  signaling  system  for  embryonic 
development  and,  in  adults,  maintenance  of  stem  cells.  Together  with  other  signaling 
pathways,  such  as  Wnt  and hedgehog,  Notch  signaling  pathway regulates  stem cell  self-
reneawel  and  is  involved  in  various  stem and  early  progenitor  cell  systems  in  both  the 
developmental and adult phases (Mofofsky et al., 2004). Adult stem cells are considered to 
maintain homeostasis of cells and tissues throughout life. The adult stem cells maintain the 
number of stem cells, as well as terminally differentiated cells, during normal turnover and 
repair damage after injury.
Involvement of Notch signaling occurs during both normal status and injury in various stem 
cell systems:
- Recently, osteoblasts have been identified as one of the bone marrow Hematopoietic Stem 
Cell (HSC) niches and Notch signaling is actively involved in HSC maintenance and growth 
in these niches (Zhang et al., 2003). Notch ligands such as Jagged1 and signal transmission to 
the Notch receptor-expressing HSCs might be one of the molecular mechanisms underlying 
the regulation of HSC in the bone marrow. 
- Involvement of Notch signaling in postdevelopmental stem cell systems is best understood 
in the skin, particularly in the hair follicles. Notch1, Notch2, and Notch3 are expressed and 
differentially localized to various layers of the hair follicle (Pan et al., 2004).
- Intestinal epithelial stem/progenitor cells are localized in the basal area of the crypts and 
continuously supply multiple types of mature cells. These cells express Notch receptors and 
molecules necessary for Notch signaling. The administration of gamma-secretase inhibitors 
induces gross histologic changes in the intestinal epithelial layer of mice, such as an increased 
number of Goblet cells, endocrine cells, and abnormal crypts (Searfoss et al., 2003, Wong et 
al., 2004, van Es et al., 2005). 
- Satellite cells are stem cells of skeletal muscle fibers. Notch signaling is insufficient for the 
regeneration of injured muscle in aged mice. Notch inhibition impairs regeneration in young 
mouse muscle, and forced Notch activation restores the regenerative potential to aged mouse 
muscle  (Conboy et  al.,  2005).  Thus,  Notch  signaling is  a  key determinant  of  the  muscle 
regenerative potential that declines with age.
1.2.7 Roles of Notch Signaling In Adult Stem Cells: Mammary gland
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The mammary gland in humans and in other mammals is a dynamic organ that undergoes 
significant developmental changes during pregnancy, lactation, and involution. It is likely that 
the cellular repertoire of the human mammary gland is generated by a stem cell component. 
These stem cells have a unique capacity for self-renewal as well as for generating the three 
lineages that comprise  the lobulo-alveolar structure of the adult  gland: myoepithelial  cells 
forming the basal layer of ducts and alveoli, ductal epithelial cells lining the lumen of ducts, 
and alveolar epithelial cells synthesizing milk proteins (Rudland et al., 1997, Hennighausen et 
al.,  2001).  Under the regulation of systemic  hormones,  as well  as local  stromal  epithelial 
interactions,  these  cells  proliferate  extensively,  differentiate  during  each  pregnancy  and 
lactation, and undergo apoptosis during mammary involution. 
A unique property of stem cells is their ability to undergo self-renewal divisions. In normal 
organogenesis this process is tightly regulated, while deregulation of self-renewal might be 
one of the key events involved in carcinogenesis (Pardal et al., 2003). 
Indeed,   cell  signaling  pathways  and transcription  factors  involved in  the  self-renewal  of 
normal  stem  cells  have  all  been  implicated  in  carcinogenesis.  These  pathways  include 
Hedgehog,  Notch  and  Wnt,  as  well  as  the  transcription  factor  B  lymphoma  Mo-MLV 
insertion region 1 (Bmi-1). The existence of self-renewing multipotent mammary stem cells 
has been clearly demonstrated by transplantation studies in mice and rats (DeOME et al., 
1996, Smith et al., 2001, Kim et al., 2000). Fragments of mammary epithelium marked with 
mouse mammary tumor virus were able to regenerate a new gland after transplantation into a 
mammary fat pad cleared of its epithelial components (Kordon et al., 1998). 
Serial  transplantation  of the clonally  derived outgrowth recapitulated  the entire  functional 
repertoire  of  the  gland,  demonstrating  the  existence  of  self-renewing  and  multipotent 
mammary stem cells.  A recent  study in mice combining long-term labeling in vivo using 
bromodeoxyuridine with immunosorting and transplantation showed that mammary stem cell 
antigen-1 (SCA-1)-positive population is enriched in progenitor cells able to regenerate the 
gland in vivo (Welm et al., 2002). The cultivation of normal mammary stem and progenitor 
cells has been limited by the lack of suitable systems that permit the propagation of these cells 
in an undifferentiated state. When primary cultures of mammary epithelium from rodents or 
humans are cultured on solid substrate, they undergo limited replication and differentiate in a 
process that is regulated by hormonal factors, extracellular matrix, and cell–cell interactions 
(Muschler et al., 1999, Romanov et al.,  2001, Reynolds et al., 1996). A major advance in 
neural stem cell research was achieved when it was found that an undifferentiated multipotent 
population of neural cells can be grown in suspension as neurospheres (Weiss et al., 1996). 
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On the basis of the hypothesis that stem cells might be able to grow in anchorage-independent 
conditions, was developed a novel culture system for human mammary epithelial stem and 
progenitor cells. In culture system in vitro, mammospheres are grown in suspension and are 
enriched  in  mammary  stem/progenitor  cells  capable  of  self-renewal  and  multi-lineage 
differentiation.  It  was  also  shown  that  mammospheres  contain  cells  capable  of  clonally 
generating complex functional  ductal  alveolar structures in reconstituted three-dimensional 
culture systems in Matrigel, and when combined with human mammary fibroblasts they are 
able to reconstitute the mammary tree in the cleared mammary fat pad of NOD/SCID mice 
(Liu  et  al.,  2006).  The  use  of  this  culture  system has  enabled  to  begin  to  elucidate  the 
pathways  that  regulate  the self-renewal  and differentiation  of  normal  mammary stem and 
progenitor cells.
Recently the mammosphere system described above was used to study the role of Notch1 
signaling in mammary cell  fate determination.  As shown in Figure 8 Notch signaling can 
increase mammospheres formation as observed by in-vitro experiments (Krause et al., 2002). 
These findings suggested that Notch1 signaling is active in several distinct  developmental 
stages  of  the  mammary gland and that  Notch  acts  as  a  regulator  of  asymmetric  cell  fate 
decisions also in mammary gland. Notch1 activation promoted the self-renewal of stem cells, 
whereas in later stages of development it biased cell fate decisions in mammary progenitor 
cells toward the adoption of a myoepithelial cell fate versus an epithelial cell fate (Dontu et 
al., 2003). 
The  Notch  pathway  was  shown  to  be  involved  also  in  the  normal  development  of  the 
mammary gland. In vitro, overexpression of the constitutively active form of Notch4 inhibits 
the differentiation of normal breast epithelial cells. Smith and colleagues also demonstrated 
that,  in vivo, Notch4 has an important role both in normal mammary development and in 
carcinogenesis. 
Recently Notch1 was shown to be a key regulator of asymmetric cell division in human breast 
epithelial stem cells (Clarke et al., 2005, Clarke et al., 2004). These findings about the role of 
Notch  in  promoting  the  self-renewal  of  mammary  stem  cells,  in  addition  to  previous 
observations that it can function as a proto-oncogene (Uyttendaele et al., 1998, Soriano et al., 
2000), suggest that abnormal Notch signaling might be involved in carcinogenesis, through 
the deregulation of normal mammary stem cell self-renewal.
The current knowledge of the Notch signaling pathway in various types of stem and early 
progenitor cells. Ex vivo stem cell expansion is fundamental to the success of stem cell-based 
regeneration medicine, and it is likely that Notch signaling has a role in stem cell expansion. 
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The  effects  of  Notch  signaling  on  progenitor  cell  survival  have  been  demonstrated,  and 
tumorigenic aspects must be considered. 
Figure 8
Figure 8. Effect of stem cell self-renewal 
a) Asymmetric stem cell self-renewal divisions result in constant mammosphere numbers in serial passages. b) Proliferation 
of stem cells or progenitor cells through restrictive divisions results in a decreasing number of spheres in serial passages 
(Notch inhibition)  (c)  Symmetric self-renewal divisions of stem cells result in an increasing number of mammospheres in 
serial passages (Notch activation). Adapted from Li uet al., 2005.
1.2.8 Notch1 and  epithelial-mesenchymal transition
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As  occurs  during  development,  Notch  cooperates  with  other  signaling  pathways  in  the 
transformation process. Notch has recently been shown to promote epithelial-to-mesenchymal 
transition  (EMT)  during  cardiac  valve  formation,  via  E-cadherin  downregulation  (Greco-
Bessa  et  al.,  2004).  One implication  of  this  work is  that  Notch,  acting  through a  similar 
mechanism, may also be involved in the EMT process that occurs during tumor progression 
and converts polarized epithelial cells into motile, invasive cells (Timmerman et al., 2004). 
1.2.9 Notch1 and angiogenesis
The realization that tumours require new blood vessels (angiogenesis) to provide oxygen and 
nutrients  led  to  many  efforts  to  develop  anticancer  therapeutics  that  block  tumour 
angiogenesis. The best validated of these approaches involves the blockade of the vascular 
endothelial growth factor (VEGF) signalling pathway, either by blocking VEGF itself or by 
blocking the primary VEGF receptor, VEGFR2. One such signalling pathway is the Notch 
system,  and recent  studies  have  focused attention  on one  particular  ligand  for  the  Notch 
receptors, Delta-like ligand 4 (DLL4), which is normally induced by VEGF as a negative-
feedback regulator of vascular growth (Thurstone et al., 2007).  Angiogenesis during tumor 
growth is also promoted by hypoxic condition and interestingly in a recent paper it was shown 
that hypoxia-induced HIF-1alfa potentiates Notch activation (Pear et al., 2005). 
In summary, the work of Gustafsson et al. has shown a link between hypoxic signaling and 
Notch. As both of these pathways are associated with multiple aspects of neoplasia, it will be 
important  to  determine  the  precise  contexts  in  which  these  pathways  influence  the 
transformed state. Hopefully, these results will guide the development of therapeutics based 
on the intersection of Notch and hypoxic signaling.  
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1.3 Notch and Cancer
1.3.1 Notch as an oncogene
The oncogenic role of Notch was first identified in human T-cell neoplasia. Some of these 
cancer cells possess a specific chromosomal translocation involving the Notch1 locus on chr.7 
and  the  T-cell-receptor-(TCR)beta  locus  on  cr.9.  The  fusion  of  these  two  loci  — t(7;9)
(q34;q34.3) — was identified in a T-cell acute lymphoblastic leukaemia (T-ALL) (Reynolds 
et al., 1987). 
Importantly, the t(7;9) translocation does not juxtapose the entire human NOTCH1 gene to 
the  TCRβ locus,  but  just  the  carboxy-terminal  region  from within  the  EGF-repeat  34  of 
NOTCH1. This leads to expression of a truncated NOTCH1 protein that corresponds to the 
cytoplasmic  portion.  As  all  T-ALLs  with  t(7;9)  translocations  show  this  feature,  it  was 
proposed  that  deregulated  expression of  the  cytoplasmic  portion  of  the  NOTCH1 protein 
causes T-ALL in humans (Figure 9). This interpretation is supported by the generation of 
mouse models for T-ALL. Mice reconstituted with haematopoietic progenitor cells expressing 
the  human  N1ICD proteins  develop  T-cell  leukaemia.  During  this  process,  they  generate 
immature  double-positive  (DP)  T  cells  in  the  bone  marrow  (Pear  et  al.,  1996)  with 
simultaneous  inhibition  of  B-cell  development,  indicating  that  NOTCH1 signalling  drives 
haematopoietic progenitor cells into the T-cell lineage (Pui et al., 1999). 
Indeed,  loss-of-function  experiments  in  which  Notch1  in  bone-marrow  progenitors  was 
inactivated, show that Notch1 is essential for normal T-cell lineage commitment. Aberrant 
N1ICD  expression  in  bone-marrow  progenitors  leads  to  immature  DP  T  cells  that  are 
developmentally blocked at this stage. These DP T cells were initially of polyclonal origin 
and not cycling (Osborne et al., 2006). With increasing time, however, these mice develop 
highly  aggressive  monoclonal  T-cell  tumours,  which  indicates  that  additional  mutations 
cooperate with N1ICD to transform non-cycling cells into aggressive, rapidly cycling tumour 
cells.  Experimentally,  Notch1  can  collaborate  with  c-Myc  (Girard  et  al.,  1996). 
Overexpression of N1ICD in haematopoietic cells gives rise exclusively to T-cell neoplasia. 
No tumours of myeloid origin have been described so far, indicating that N1ICD cooperates 
with  T-cell-specific  signals  to  exert  its  oncogenic  potential..  Proviral  integration  of  the 
Moloney murine leukaemia virus (MuLV) or feline leukaemia virus into Notch1 or Notch2, 
respectively,  causes T-cell  leukaemia (Girard et  al.,  1996).  In both cases, the cytoplasmic 
domain  of  the  Notch  proteins  is  expressed  under  the  influence  of  the  viral  promoter. 
Consistent with these findings, forced expression of the Notch ligand Dll4 also results in the 
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development of T-cell leukaemia (Yan et al., 2001) and T-cell lymphoproliferative disease in 
another (Dorsh et al., 2002). Finally, Notch activity participates not only in the initiation of 
cancers, but also in their maintenance, as shown by Weng et al. for Notch-transformed T-ALL 
cells (Weng et al., 2003).  
                       
Figure 9. Notch1 in T-ALL
Schematic rappresentation of translocation occuring in T-ALL between cr.7 and 9. This leads to the expression of truncated 
Notch1 transcripts (N1ICD) from the TCRbeta promoter, causing T-ALL. From Radtke et al., 2003.
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1.3.2 Other tumors
Based  on  the  known  role  of  Notch  signaling  in  regulating  epithelial  differentiation  in 
developing mouse pancreas recently it has been found that the Notch pathway activation is a 
direct  consequence  of  EGF  receptor  signaling  in  exocrine  pancreas.  Moreover,  it  was 
demonstrated that Notch is a requisite downstream mediator of TGF-alfa induced changes in 
epithelial differentiation (Myamoto et al., 2007). 
These studies  define a  novel role  for Notch in regulating  metaplastic  conversion between 
epithelial cell types and suggest an important link between EGF receptor signaling and Notch 
pathway activation in the context of pancreas tumorigenesis. Deregulated expression of Notch 
receptors, ligands, and targets is also observed in other solid tumors, including cervical, head 
and  neck,  endometrial,  renal,  lung,  ovarian,  and  prostate  carcinomas,  osteosarcoma, 
mesothelioma, gliomas, and medulloblastomas (Zagouras et al., 1995, Dang et al., 2000, Rae 
et al., 2000, Santagata et al., 2004, Hopfer et al., 2005, Fan et al., 2004, Pupow et al., 2005, 
Weijzen et al., 2002, Bocchetta et al., 2003, Hendrix et al., 2002 ). High-level expression of 
Notch-1 and Jagged-1 is associated with metastasis in prostate cancer (Santagata et al., 2004). 
Hodgkin's lymphomas, anaplastic large-cell non-Hodgkin's lymphomas, some acute myeloid 
leukemias, B-cell chronic lymphoid leukemias, and multiple myeloma also show deregulated 
expression of Notch receptors or ligands .
1.3.3 Breast Cancer
Several studies highlight the potential importance of the Notch1 signaling pathway in human 
breast cancer and underscore the necessity for future studies to better understand how this 
gene contributes to mammary epithelial cell transformation. The ﬁrst evidence that aberrant 
Notch1 signaling might play a role in mammary tumorigenesis came from the identiﬁcation of 
MMTV insertions in the Notch1 locus in MMTV-Neu mammary tumors (Dievart et al., 1999). 
To identify genes that collaborate with  Neu/erbB2 in mammary tumorigenesis, MMTV-Neu 
mice were infected with the MMTV virus and tumors arising in these mice were analysed to 
identify  the  insertion  sites  of  the  MMTV provirus.  Surprisingly,  in  MMTV-Neu tumors, 
Wnt-1 was  the  only  affected  locus  (4/24  tumors)  among  the  genes  previously  known as 
affected by MMTV insertion (Callahan et al., 1996). However, in 2/24 tumors the MMTV 
provirus had inserted into the  Notch1 locus. These insertions caused rearrangements in the 
Notch1 gene  leading  to  expression  of  a  truncated  Notch1  protein.  Both  of  the  MMTV 
insertions into the Notch1 locus occurred upstream of the Notch1 transmembrane domain, in a 
manner  similar  to that  observed in  Notch4(int-3) mammary gland tumors  (Robbins et  al., 
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1992), leading to expression of the constitutively active intracellular domain of Notch1. The 
absence of MMTV insertions into the majority of loci  previously identiﬁed as targets  for 
provirus insertion indicates that, in the context of an erbB2/Neu transformed mammary gland, 
disruption of speciﬁc loci may be selected for and contribute to the tumorigenic process. 
Thus, Wnt-1 and Notch1 may contribute to Neu-induced tumorigenesis, instead other MMTV 
integrations do not. Alternatively, analysis of a greater number of MMTV-infected/MMTV-
Neu transgenic mice may reveal additional MMTV integration sites involved in breast cancer 
tumorigenesis. 
A recent study has implicated Notch1 in human mammary tumorigenesis and also provides 
insight into the possible mechanism by which Notch1 exerts its tumorigenic effect (Weijzen et 
al., 2002). An assessment of human breast cancer cases demonstrated that of seven human 
breast tumors analyzed, Notch1 was highly expressed in all of the cases and the highest levels 
of Notch1 expression were observed in Ras-positive tumors (Weijzen et al., 2002). In the Ras-
transformed ﬁbroblasts, downregulation of Notch1 expression using antisense technology led 
to a signiﬁcant decrease in the proliferation rate of these cells. Moreover, inhibition of Ras 
signaling blocked upregulation of N1ICD indicating that Ras acts  upstream of Notch1. In 
addition,  expression of  oncogenic  Ras  led  to  higher  levels  of  Delta-like1  and Presenilin1 
proteins, which may increase Notch1 processing thus accounting for the high levels of the 
Notch1  intracellular  cleavage  product  found  in  these  cells.  Importantly,  hTERT/SV40  T 
antigen-expressing human ﬁbroblasts expressing N1ICD proliferate more rapidly than control 
cells and form colonies in soft agar, highlighting the possibility that N1ICD may mediate, at 
least in part, the tumorigenic effects of oncogenic Ras. Furthermore, cleavage of Notch1 is 
induced by the MAPK/SAPK pathway upon oncogenic Ras activation. These studies indicate 
that, crosstalk between Ras and Notch1 may play a role in the tumorigenic process. 
To  investigate  the  consequences  of  modulating  Notch  activity  in  the  murine  mammary 
epithelium, mouse lines were generated carrying MMTV LTR-driven transgenes encoding a 
constitutively activated form of the human Notch1 receptor (hN1ICD) (Kiaris et al., 2004). In 
the  case  of  the  MMTV-hN1ICD  animals,  they  develop  lactation-dependent  tumors  that, 
however,  regress  at  weaning,  because  the  neoplastic  cells  apparently  retain  the  ability  to 
respond to apoptotic cues encountered during the process of mammary involution. Eventually, 
these  regressing  neoplasms  apparently  evolve  into  nonregressing  adenocarcinomas. 
Moreover, by exploring the phenotypic consequences of antagonizing the endogenous Notch 
activity in the mammary epithelium through the transgenic expression of Deltex, cyclin D1 
was found to be an in vivo target of Notch1 signals. Consistent with this observation, it was 
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shown that Ras-induced tumorigenesis, which depends on the presence of cyclin D1 activity, 
can be suppressed by expressing Deltex (Kiaris et al., 2004).
The demonstration that the expression of Deltex interferes with Ras-driven oncogenesis in the 
mammary gland is also an indication, that the mammary tissue is sensitive to Notch signals 
and consequently suggests the existence of a crosstalk between Ras and Notch signals in this 
tissue via  cyclin  D1.  Indeed,  Cyclin  D1 overexpression is  now established  as  a  common 
feature  of  many human tumors  (Hulit  et  al.,  2004,).  Thus,  cyclin  D1 transcription  is  up-
regulated in Notch1-induced murine mammary tumors that arise during lactation (Kiars et al., 
2004). In rat kidney epithelial cells containing an estrogen-inducible activated Notch1 (RKE-
ER-N1ICD), cyclin D1 mRNA levels increase when the N1ICD is activated and the cells are 
transformed  (Ronchini  et  al.,  2000).  Thus,  cyclin  D1  transcription  might  have  been  up-
regulated  in  RKE-ER-N1ICD  or  by  a  mitogen-activated  signal  transduction  pathway 
(Albanese et al., 1995). 
Recent data showed that the expected high level of N1ICD transgene expression in tumors 
resulted in up-regulation of known Notch1 transcriptional targets, such as Hes1 and Hey1, and 
was paralleled by high Myc transcript levels. Indeed Myc is a direct Notch1 target.  These 
results   unveil  a  Notch1/Myc  relationship  by using  this  mouse  model  that  documented  a 
strong  association  between  high  levels  of  Notch1  and  Myc  expression  in  human  breast 
cancers.
Interestingly,  recent evidence suggests that Wnt or Notch signaling may also be deregulated 
in human breast cancer (Ayyanan et al., 2006). Indeed, increased Wnt signaling is sufficient 
to cause transformation of primary HMECs (human mammary epithelial  cells),  with early 
activation  of  the  DDR  followed  by  a  cascade  of  events  resulting  in  the  tumorigenic 
phenotype.  Expression  of  Notch  ligands  Dll1,  Dll3,  and  Dll4  is  increased,  and  Notch 
activation  is  required  for  Wnt-induced  transformation  both  in  vitro  and  in  vivo.  Finally, 
analysis of a substantial number of human breast carcinomas indicates that these findings are 
likely to be relevant to the clinical situation. 
Therefore,  both  Wnt  and  Notch  signaling  pathways  are  important  in  maintaining  and 
amplifying progenitor cells in different tissues (Koriken et al., 1998), including the breast (Li 
et al., 2005). 
Thus, in concomitance with the biochemical events described above, a further factor to be 
considered  is  the  existence  of  subpopulations  of  HMECs  with  different  susceptibility  to 
malignant transformation that may be selectively amplified by activation of Wnt and/or Notch 
signaling pathways.
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The  crosstalk  between  these  pathways  may  impinge  especially  on  early  steps  of  breast 
carcinogenesis, with potential impact on novel treatments and/or prevention of breast cancer.
1.3.4 Clinical DATA
Aberrant activation of Notch receptors has been shown to cause mammary tumors in mice and 
recently Notch1 and the Notch ligand Jagged1 overexpression are also associated with poor 
clinical outcomes in human breast cancer (Reedijk et al., 2005). 
Recently in situ hybridization was used to analyze expression of Notch ligands and receptors 
in human breast cancer. High levels of JAG1 and Notch1 were noted in a subset of tumors 
with poor prognosis pathologic features. Patients with tumors expressing high levels of JAG1 
or Notch1 had a significantly poorer overall survival compared with patients expressing low 
levels of these genes. These data (a) identify novel prognostic markers for breast cancer, (b) 
suggest a mechanism whereby Notch is activated in aggressive breast tumors, and (c) may 
identify  a  signaling  pathway  activated  in  poor  prognosis  breast  cancer  which  can  be 
therapeutically targeted. 
Recently, same results have been obtained through immunohistochemical analysis of the same 
breast cancer cases (N=127) that patients with tumors expressing high levels of JAG1 protein 
had a worse outcome than those with tumors expressing low levels (Dikson et al., 2007). It 
was also describe that when tumors were classified as either high or low for JAG1 mRNA or 
protein expression, there was only 65% agreement between the two methods of expression 
analysis.  When  JAG1  mRNA  and  protein  data  were  combined,  patients  with  tumors 
expressing low levels  of both had a 10-year  survival of 53% and median survival of 131 
months. In comparison, patients with tumors expressing either high levels of JAG1 protein, 
mRNA or both had reduced 10-year survival and median survival  (31%, 19%, 11% and 77, 
43, 23 months respectively; P<0.0001). 
These data show that quantification of JAG1 mRNA and protein levels in breast cancer can be 
used to identify patients who have a significant survival disadvantage and who may benefit 
from therapies (such as gamma-secretase inhibitors) that target signaling through the Notch 
pathway.
A much clearer indication has come from two surveys examining Numb expression (Pece et 
al., 2004), a negative regulator of Notch pathway, and the mRNA levels of Notch receptors 
and  their  ligands  (Reedijk  et  al.,  2005)  in  breast  carcinoma  samples.  Numb  was 
downregulated in about 50% of tumors due to ubiquitination and proteosomal degradation, 
and its levels were inversely correlated with grade and proliferation rate (Pece et al., 2004)
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(Table1).  Furthermore,  the  authors  showed  that  colony  formation  was  reduced  by 
reintroducing Numb into epithelial cells derived from Numb-negative tumors. 
                    
             
Table1. Correlation between Numb status and clinical-pathological features.
Class 1-3 define three types of tumors with different Numb immunoreactivity. 
Class-1 (38.3% of the cases) tumors showed Numb staining in <10% of the neoplastic cells, whereas class-2 and -3 tumors 
(16.8% and 44.9% of investigated cases, respectively) showed Numb immunoreactivity in 10–50% and >50% of the tumor 
cells, respectively. Thus, more than one half of all breast tumors (classes 1 and 2 combined) had reduced levels of Numb.  
Remarkably, a strong inverse correlation was found between Numb expression levels and tumor grade (P = 0.001) and Ki67 
labeling  index  (P  =  0.001),  which  are  known  indicators  of  aggressive  disease.  N,  number  of  tumors  analyzed;  Ki67, 
proliferative index; LN, lymph nodes. P value was obtained using the Mantel-Haenszel Chi square statistics. 
Adapted from Pece et al., 2004
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1.3.5 Notch and p53
A mechamism by which Notch1 modulates cellular transformation is the negative role of Not­
ch signaling on p53 transactivation function (Kim et al., 2007). The N-terminal fragment of 
N1ICD, which can interact with p53, inhibits p53 phosphorylation and represses p53 transac­
tivation. In addition, Notch signaling downregulated p53-dependent apoptosis induced by UV 
irradiation.
Others studies confirm the crosstalk between Notch1 and p53 pathways. It was shown that 
cells expressing N1ICD are chemoresistant in a wild-type p53-dependent manner (Mungamu­
ri et al., 2006). 
Additionally, a new function for human Numb has been described as a regulator of tumor pro­
tein p53 (Colaluca et al., 2008). Numb enters in a tricomplex with p53 and the E3 ubiquitin li­
gase HDM2 (also known as MDM2), thereby preventing ubiquitination and degradation of 
p53. This results in increased p53 protein levels and activity, and in regulation of p53-depen­
dent phenotypes. Biologically, this results in an aggressive tumour phenotype, as witnessed by 
findings that Numb-defective breast tumours display poor prognosis. 
As said above, aberrant Notch signaling contributes to more than half of all human T-cell leu­
kemias, and accumulating evidence indicates Notch involvement in other human neoplasms. 
Recently it was shown that Notch suppresses p53 in lymphomagenesis through repression of 
the ARF-mdm2-p53 tumor surveillance network. This shows that continued Notch activity is 
required to maintain the disease state. Furthermore, it was proposed that suppression of p53 
by Notch is a key mechanism underlying the initiation of T-cell lymphoma.
1.3.6 Notch Inhibitors as Cancer Therapeutics 
Numerous  studies  have  proposed  inhibition  of  Notch  signaling  as  a  strategy  for  cancer 
treatment  (Nickoloff  et  al.,  2003).  Selective  strategies  include  antisense,  monoclonal 
antibodies,  and  RNA  interference.  Nonselective  strategies  include  gamma-secretase 
inhibitors,  and  Ras  signaling  inhibitors.  gamma-Secretase  inhibitors  (GSI)  have  the  most 
immediate  therapeutic  potential.  GSI cbz-IL-CHO has Notch-1 – dependent  antineoplastic 
activity in Ras-transformed fibroblasts (Weijzen et al., 2002). 
Like other small-molecule agents, GSIs have multiple effects. Gamma-Secretase cleaves all 
Notch  receptors  and  some  ligands  but  also  ErbB4,  syndecan,  CD44,  and  other  proteins 
(Nickoloff  et  al.,  2003,  Kopan  et  al.,  2004).  Therapeutically,  this  may  actually  be 
advantageous  because  many cancers  coexpress  two or  three  different  Notch  homologues. 
Some GSIs  may also affect  proteases  other  than  gamma-secretase.  Pharmacologic  studies 
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with GSIs need to carefully address target specificity,  and a complementary transcriptional 
silencing approach is necessary in each model. Accumulating preclinical evidence has led to 
the opening of phase 1 trials of a GSI in T-ALL and breast cancer (Miele et al., 2006). 
The pathways affected by Notch inhibition are likely to be context dependent, and rational 
combinations  of  GSIs  with  other  antineoplastic  drugs  will  require  mechanistic  studies  in 
individual models (Miele et al.,  2006). Looking beyond GSIs, ADAM inhibitors may find 
clinical uses to inhibit the first ligand-induced Notch cleavage. In light of recent evidence, 
blocking  specific  E3  ligases  responsible  for  ubiquitination  of  Notch  ligands  or 
monoubiquitination of Notch receptors may be an alternate approach. Small molecules that 
interfere with Notch coactivator binding may selectively inhibit CSL signaling but not non-
canonical signaling. Depending on the relative importance of Notch downstream pathways in 
individual cancers and normal tissues, this may be an advantage or a disadvantage compared 
with  drugs  that  block  receptor  activation.  An  important  question  is  whether  selective 
inhibition of one of the four Notch homologues may be therapeutically desirable. Finally, it 
will be important to establish whether cancer stem cell – targeted agents are optimally active 
alone or in rational combinations (e.g., a Notch inhibitor with a Hedgehog inhibitor). 
1.3.7 Notch1 as tumour suppressor 
Evidence that Notch signalling is not exclusively oncogenic but is also tumour suppressive 
comes  from  studies  on  skin.  The  epithelium  of  the  skin  comprises  several  layers  of 
keratinocytes  that  are  at  various  stages  of  terminal  differentiation.  In  normal  tissue, 
proliferating keratinocytes are present mainly in the basal layer of the epithelium. Basal cells 
proliferate for a limited number of times before initiating terminal differentiation. This event 
is  marked  by  their  migration  to  the  next  layer  (the  spinous  layer)  where  the  cells  cease 
proliferation and become committed to terminal differentiation. 
Notch1  and  Notch2,  as  well  as  Jagged1  and  Jagged2,  are  exclusively  expressed  in  the 
suprabasal layers of murine epidermis (Rangarajan et al., 2001). 
Notch signaling also promotes commitment of keratinocytes to differentiation and suppresses 
tumorigenesis.  p63,  a  p53  family  member,  has  been  implicated  in  establishment  of  the 
keratinocyte cell fate and/or maintenance of epithelial self-renewal. It was shown that p63 
expression  is  suppressed  by  Notch1  activation  in  both  mouse  and  human  keratinocytes 
(Nguyen et al., 2006). In turn, elevated p63 expression counteracts the ability of Notch1 to 
restrict growth and promote differentiation. p63 functions as a selective modulator of Notch1-
dependent transcription and function, with the Hes-1 gene as one of its direct negative targets. 
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Thus,  a  complex  cross-talk  between  Notch  and  p63  is  involved  in  the  balance  between 
keratinocyte self-renewal and differentiation.
1.4 The Prolyl-isomerase Pin1
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1.4.1 Phosphorylation of proteins on Ser/Thr-Pro motifs
Post-translational modifications of proteins, such as phosphorylation, are important signalling 
mechanisms  involved  in  many  cellular  pathways,  such  as  those  controlling  cell  cycle, 
transcription,  DNA  repair,  cell  differentiation  and  proliferation.  The  phosphorylation  of 
proteins on serine or threonine residues that immediately precede a proline (pSer/Thr-Pro) is a 
central  signaling mechanism that  has  been shown to play an important  role  in regulating 
different  biological  processes  and  pathological  conditions  (Lu  et  al.,  2002).  Ser/Thr-Pro 
motifs are exclusive phosphorylation sites for a large number of Pro-directed protein kinases 
that play essential  roles in signal trasduction and cell  cycle  progression. These include all 
cyclin-dependent kinases (CDKs), which control cell cycle transition, as well as most of the 
mitogen-activated protein kinases (MAPKs), and glycogen synthase kinase 3 (GSK-3). 
Many oncogenes and tumor suppressors themselves  are  directly regulated by Pro-directed 
phosphorylation and/or trigger signalling pathways involving Pro-directed phosphorylation. 
The peptidyl-prolyl  cis/trans isomerase  Pin1 has  been identified  and characterized,  which 
specifically  regulates  the  conformation  of  specific  Pro-directed  phosphorylation  sites  in 
certain proteins (Ranganathan et  al.,  1997). Pin1 is a peptidyl–prolyl  isomerase that binds 
specifically to those motifs upon phosphorylation thereby switching the intervening peptide 
bond  from  cis  to  trans  conformation  and  vice  versa,  providing  an  additional  level  of 
regulation (Yaffe et al., 1997) (Fig.10). 
1.4.2 The prolyl-isomerase Pin1
The  human  Pin1  isomerase  gene  maps  to  the  chromosome  19p13  and  Pin1  protein  is  a 
member of the evolutionarly conserved peptidyl-prolyl isomerase (PPIase) family of proteins. 
Prolyl isomerases comprise three structurally distinct subfamilies; the cyclophilins, FK506-
binding proteins  (FKBP) and the parvulins.  Pin1 is  a parvulin  of  approximately 18 kDa 
protein composed of two functional domains, an aminoterminal WW domain (amino acids 1–
39)(Yeh et al., 2007) involved in protein–protein interaction, and a COOH-terminal PPIase 
domain (amino acids 45–163) that functions as isomerase (Figure 10). These two domains are 
separated by a short  flexible  linker region.  Pin1 is  unique from the other parvulin family 
members because it recognizes Ser/Thr–Pro motifs only following phosphorylation, working 
in concert with protein kinases that phosphorylate these motifs as well as protein phosphatases 
that  dephosphorylate  them to control the activity and/or stability of their common targets. 
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PIN1 was discovered through a yeast  two-hybrid screen designed to identify proteins that 
interact  with never  in  mitosis  gene A (NIMA), an essential  mitotic  kinase in  Aspergillus 
nidulans (Lu et al., 1996). The overexpression of NIMA in yeast is lethal because it induces 
premature  chromosome  condensation  followed by cell  death.  The  overexpression  of  Pin1 
prevented this, therefore it was suggested that Pin1 might function as a regulator of mitosis. 
           
Figure 10. Pin1 structure and function
The protein Pin1 is shown in the upper part of the figure. Pin1 is an 18 kDa protein consisting of a WW binding domain and a 
PPiase catalytic domain. The lower part of the figure shows convertion of the conformation of the target protein from cis to 
trans conformation and vice versa. Adapted from  Yeh et al., 2007.
1.4.3 Pin1 is involved in several cellular processes
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Given numerous phosphorylated substrates of Pin1 it is involved in several aspects of cellular 
processes:
-  Evidences  was  recently  provided  that  Pin1  has  an  important  function  in  chromosome 
condensation during mitosis. It was demonstrated that the interaction of Pin1 with chromatin 
is greatly elevated in G2/M phase and that this correlates with the presence on chromosomes 
of  several  mitotic  phosphoproteins,  especially  topoisomerase(Topo)IIα(Xu  et  al.,  2007). 
Indeed,  purified  Pin1  and  cdc2/cyclin  B  kinase  were  by  themselves  sufficient  to  induce 
condensation.  This  reflects  the  ability  of  Pin1  to  increase  TopoIIα phosphorylation  by 
cdc2/cyclinB in vitro, which in turn dramatically increased formation of a TopoIIα/Pin1/DNA 
complex. 
- Interestingly the peptidyl prolyl isomerase Pin1 modulates also RNAP II function during the 
cell cycle  (Xu et al., 2007b). Several assays indicate that the inhibition largely reflects Pin1 
activity  during transcription  initiation  and not  elongation,  suggesting  that  Pin1  modulates 
RNAP II activity, during an early stage of the transcription cycle. 
- Another physiological function of Pin1 is regulating fibroblast proliferation and extracellular 
matrix deposition. Eosinophilic inflammation is due to chronic asthma that often culminates 
in subepithelial fibrosis with variable airway obstruction. Pulmonary eosinophils (Eos) are a 
predominant source of TGF-β1, which drives fibroblast proliferation and extracellular matrix 
deposition.  Pharmacologic  blockade  of  Pin1  in  a  rat  asthma  model  selectively  reduced 
eosinophilic  pulmonary  inflammation,  TGF-β1  and  collagen  expression,  and  airway 
remodeling.  These  data  suggest  that  pharmacologic  suppression  of  Pin1  may  be  a  novel 
therapeutic option to prevent airway fibrosis in individuals with chronic asthma (Shen et al., 
2008).
-  Another  function of Pin1 is  to regulate  B cells.  Antigen-specific  B cells  are selected in 
germinal centers, the structure in which these cells proliferate while accomplishing genome-
remodeling processes such as class-switch recombination and somatic hypermutation. These 
events  are  associated  with  considerable  genotoxic  stress,  which  cells  tolerate  through 
suppression  of  DNA-damage  responses  by  Bcl-6,  a  transcription  factor  required  for  the 
formation of germinal  centers.  Interestingly the expression of Bcl-6 is  regulated  by DNA 
damage through a signaling pathway that promotes Bcl-6 degradation. After DNA damage 
has accumulated, the kinase ATM promotes Bcl-6 phosphorylation, leading to its interaction 
with the isomerase Pin1 and its degradation by the ubiquitin-proteasome system (Phan et al., 
2007).  Because Bcl-6 is  required  for  the maintenance  of  germinal  centers,  these findings 
suggest that  the extent of genotoxic stress controls the fate of germinal center B cells  by 
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means of Bcl-6.
1.4.4 Pin1 mouse models
Mice knock-out for  Pin1 gene in a mixed background (129SvJae/C57BL/6) develop tissue 
defects as they age. Such defects include retinal atrophy, decreased body weight, testicular 
atrophy and lack of breast epithelial expansion during pregnancy (Liou et al., 2002). 
Most  of  these  phenotypes  are  remarkably  similar  to  those  of  cyclin  D1-deficient  mouse 
phenotypes.  Of several phenotypes ob served in Pin1-/- mice,  the alterations in retina and 
mammary gland seemed to be most drastic. Pin1-/- mice show dramatic impairments in cell 
survival or proliferation in the retina, especially at old age. Moreover, it is very clear and 
striking that  in  pregnant  Pin1-/-  female,  mammary epithelia  cells  fail  to undergo massive 
proliferation  in  the  development  of  alveolar  structures  and ductal  side branching.  Pin1 is 
highly expressed in retina and mammary gland compared with other tissues, and the depletion 
of Pin1 causes a dramatic retinal atrophy and mam mary gland impairment (Liou et al., 2002). 
In another study both male and female Pin1-null mice on imbred C57BL/6 showed a reduced 
number of germ cells owing to an impairment in primordial germ cell (PGC) expansion, and 
led to a profound decrease in fertility (Atchinson et al., 2003). Although Pin1 depletion was 
previously reported to lead to apoptosis or mitotic arrest, neither of these defects occurred in 
the PGCs. Instead, the PGCs had a marked increase in duration of the cell cycle owing to a 
prolonged G1–S transition. These studies indicated that Pin1 is important in controlling the 
G1–S phase transition (Atchinson et al., 2003).
1.4.5 Pin1 and cell-cycle checkpoints
-  Analyses  of Pin1-null  mouse  embryo  fibroblasts  (MEFs) from mice of a mixed genetic 
background  (129SvJae/C57BL/6)  provide  additional  support  for  a  role  of  PIN1  in 
proliferation that is unrelated to its function in mitosis(Fujimori et al., 1999). Fujimori et al. 
found that Pin1-null MEFs showed slower growth than wild-type MEFs. Moreover, Pin1-/- 
MEFs rendered quiescent owing to serum deprivation were markedly delayed in cell cycle re-
entry  in  response  to  stimulation  with  serum.  Additional  studies  by an  independent  group 
confirmed these growth defects by showing that serum-arrested Pin1-/- MEFs were resistant 
to cell cycle re-entry in response to insulin-like growth factor 1 (IGF1)(You et al., 20002). 
Moreover, following this delayed return to asynchronous growth, Pin1-/- MEFs had slower 
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doubling times than wild-type MEFs. These results are supported by a study in A. nidulans 
showing that reduced expression levels of PINA (the gene that encodes Pin1) result in an 
increase in the time required to complete a nuclear division cycle, which was primarily due to 
the lengthening of the G1–S transition(Joseph et al., 2004). Finally, it has been reported that 
the expression of Pin1 is positively regulated by E2F such that Pin1 expression is increased as 
cells progress from G0 into the S phase of the cell cycle(Ryo et al., 2002). These results, 
together with those from both mixed and C57BL/6 Pin1-null mice, indicate that PIN1 has a 
role  in  in  G0–G1–S  progression  in  addition  to  its  originally  proposed  role  in  mitotic 
progression.
Recently has been developed a screening method to isolate Pin1 inhibitors (Uchida et al., 
2003). The chemical library screen identified PiB as the most potent inhibitors with IC50s of 
1.5  μM.  For  comparison,  juglone,  the  only  previously  reported  Pin1  inhibitor,  which  is 
irreversible and rather nonspecific has an IC50 of 5  μM. PiB has antiproliferative activity 
against  a variety of cancer  cell  lines.  Pin1 expression levels  differed between the various 
cancer cell lines and cells with a low level Pin1 were less sensitive to inhibitor treatment than 
cells expressing high levels of Pin1. The effects of PiB on the growth of wild-type and Pin1-/- 
MEFs were also examined. PiB inhibited proliferation of wild-type MEF whereas the same 
concentration did not inhibit the growth of Pin1-/- MEFs. 
The  results  suggest  that  one  of  the  targets  of  PiB is  Pin1  and  that  inhibition  of  Pin1  is 
apparently important for the antiproliferative activity of PiB. However, this does not rule out 
the possibility that PiB may have other targets in addition to Pin1 (Uchida et al., 2003). 
- During the G0/G1-S phase transition, the timely synthesis and degradation of key regulatory 
proteins  is  required  for  normal  cell  cycle  progression.  Two of  these  proteins,  c-Myc  and 
cyclin E, are recognized by the FBW7alfa E3 ligase of the Skp1/Cul1/Rbx1 (SCF) complex. 
FBW7 binds to a similar phosphodegron sequence in c-Myc and cyclin E proteins resulting in 
ubiquitylation and degradation of both proteins via the 26 S proteosome (van Drogen et al., 
2006).
SCF(FBW7alpha)  binds  a  complex  containing  cyclin  E,  Cdk2,  and  the  prolyl  cis/trans 
isomerase Pin1 and promotes the activity of Pin1 without directly ubiquitylating cyclin E (van 
Drogen et al., 2006). However, due to the action of this FBW7alfa-Pin1 complex, cyclin E 
becomes an efficient ubiquitylation substrate of FBW7gamma. 
It  was  also  shown  that  Pin1  also  regulates  the  turnover  of  cyclin  E  in  mouse  embryo 
fibroblasts (Yeh et al., 2006). The absence of Pin1 results in an increased steady-state level of 
cyclin E and stalling of the cells in the G1/S phase of the cell cycle. The cellular changes that 
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result from the loss of Pin1 predispose Pin1 null mouse embryo fibroblasts to undergo more 
rapid genomic instability when immortalized by conditional inactivation of p53 and sensitizes 
these cells to more aggressive Ras-dependent transformation and tumorigenesis.
The stability of c-Myc is regulated by multiple Ras effector pathways. It was shown that Ser 
62 is dephosphorylated by protein phosphatase 2A (PP2A) before ubiquitination of c-Myc, 
and that PP2A activity is regulated by the Pin1 prolyl isomerase. Furthermore, the absence of 
Pin1 or inhibition of PP2A stabilizes c-MycThus, Ras-dependent signalling cascades ensure 
transient and self-limiting accumulation of c-Myc, disruption of which contributes to human 
cell oncogenesis.
- There is emerging evidence that Pin1 regulates the function of the p53 family of tumour sup­
pressors in response to genotoxic insults. The p53 family members p53 and p73 both undergo 
proline-directed phosphorylation after DNA damage or stress exposure. Pin1 can directly bind 
to, and presumably isomerize, multiple phosphorylated Ser/Thr-Pro motifs in p53 (Ser 33, Ser 
46, Thr 81 and Ser 315) and p73 (Ser 412, Thr 442 and Thr 482) (Zacchi et al., 2002, Manto­
vani et al., 2004, Wulf et al., 2002, Zheng et al., 2002). As a result, Pin1 increases the protein 
half-life of p53 by inhibiting its binding to the Mdm2 ubiquitin ligase, which regulates the 
degradation of p53. Furthermore, recently it was found that Pin1 is required for efficient loa­
ding  of  p53 on  target  promoters  upon stress.  Accordingly,  tumor-associated  mutations  at 
Pin1-binding residues within the p53 proline-rich domain hamper acetylation of p53 by p300. 
After phosphorylation of p53 at Ser46 triggered by cytotoxic stimuli, Pin1 also mediates p53's 
dissociation  from the  apoptosis  inhibitor  iASPP,  promoting  cell  death.  In  tumors  bearing 
wild-type p53, expression of Pin1 and iASPP are inversely correlated, supporting the clinical 
relevance of these interactions (Mantovani et al., 2007).  Pin1 also increases the stability of 
p73 by promoting its binding to and acetylation by p300. At the same time, Pin1 enhances the 
DNA-binding activity and transcriptional activity of p73 towards its target genes. Functional­
ly, Pin1 seems to be required for maintaining DNA damage checkpoints, protecting against 
DNA-damage-induced apoptosis, and also to accelerate p53-dependent apoptosis by enhanc­
ing pro-apoptotic genes. However, these studies have been restricted to cell lines or embryon­
ic fibroblasts, and it remains unclear to what extent Pin1-dependent regulation of p53 or p73 
contributes to the DNA damage response in vivo, or even to tumour suppression. To investi­
gate the physiological relationship between Pin1 and p53 and Notch1, recently Pin1-/-p53-/- 
mice were created (Takahashi et al., 2007). P53-deficient mice spontaneously developed lym­
phomas, mainly of thymic origin, as well as generalized lymphoma infiltration into other or­
gans, including the liver, kidneys and lungs. Ablation of Pin1, in addition to p53, accelerated 
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the thymic hyperplasia, but the thymocytes in these Pin1-/-p53-/- mice did not infiltrate other 
organs. The thymocytes in Pin1-/-p53-/- mice had significantly higher levels of N1ICD than 
the thymocytes of p53-/- or wild-type mice. These results suggest that Pin1 control the proli­
feration and differentiation by regulating the N1ICD level, but these data have been obtained 
in the absence of p53 and in thymocytes. 
1.4.6 Pin1 and cancer
A connection between Pin1 and cancer was first suggested when Pin1 was observed to be 
overexpressed in human cancer tissues (Wulf et al., 2001, Ryo et al., 2001). More extensive 
studies  revealed  that  (with  very few exceptions,  such as  neurons)  in  normal  tissues  Pin1 
expression is associated with cell  proliferation,  and that it  is  overexpressed prevalently in 
human cancers, including cancer of the breast, prostate, lung and colon (Bao et al., 2004). 
Furthermore,  increased  Pin1  levels  are  highly  predictive  of  cancer  recurrence  after 
prostatectomy (Ayala et al., 2003). Analysis of molecular markers for cancer revealed a close 
correlation between Pin1 and cyclin D1 (Wulf et al., 2001). Because cyclin D1 is an important 
cell-cycle regulator that is known to have a key role in the development of many cancers, this 
connection has led to a series of in vitro and in vivo studies that demonstrate an essential role 
of Pin1 in regulating cyclin D1 expression and turnover through multiple mechanisms )Wulf 
et al., 2001, Ryo et al., 2001, Liou et al., 2002) (Fig. 1). Phosphorylation of cyclin D1 by 
glycogen synthase kinase-3beta (GSK-3beta) on the pThr 286-Pro motif promotes its nuclear 
export and subsequent ubiquitin-mediated degradation. However, Pin1 can directly bind to 
and  presumably  isomerize  the  pThr  286-Pro  motif  of  cyclin  D1  and  thereby  prevent  its 
nuclear export and ubiquitin-mediated degradation, resulting in cyclin D1 stabilization (Lou et 
al., 2002). Furthermore, Pin1 can also regulate cyclin D1 gene expression by at least three 
different mechanisms. 
First,  following the activation of c-Jun N-terminal  kinases (JNKs) in  response to growth-
stimulating conditions, Pin1 can target to the pSer 63/73-Pro motifs in c-Jun and increase c-
Jun transcriptional activity towards its target genes such as cyclin D1 (Wulf et al., 2001)). 
Because c-Jun has been shown to be subjected to ubiquitin-mediated degradation in a JNK-
dependent manner, it is possible that Pin1 might increase protein stability of c-Jun, although it 
has not been examined. 
Second, Pin1 can target to the pThr 246-Pro motif in beta-catenin and prevent beta-catenin 
from interacting with the tumour suppressor APC (adenomatous polyposis coli gene product). 
This  enhances  transcriptional  activity  of  beta-catenin  towards  its  target  genes,  including 
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cyclin D1, as do many genetic mutations in beta-catenin or APC that are found in human 
cancer (Moon et al., 2002). Consistent with this notion, Pin1 overexpression and beta-catenin 
gene  mutations  have  recently  been  shown  to  be  distinct  oncogenic  events  in  human 
hepatocellular carcinoma (Pang et al., 2004). 
Third, after cytokine treatment, Pin1 can target to the pThr 254-Pro motif in the p65/RelA 
subunit of NF-kappaB and prevent NF-kappaB from binding to its inhibitor IkappaB. This 
prevents  p65/RelA nuclear  export  and its  subsequent  degradation  by a ubiquitin-mediated 
pathway (Ryo et al., 2003). This leads to enhanced nuclear accumulation, protein stability and 
transcriptional activity of NF-kappaB towards its target genes such as cyclin D1 and IkappaB. 
This may provide an explanation for the puzzling phenomenon that NF-kappaB activity is 
upregulated in the presence of elevated IkappaB in some cancer samples. 
With the same net result of enhancing pro-proliferative signalling, Pin1 also inhibits negative 
feedback of MAPK signalling: in response to growth-stimulating conditions, Raf kinase is 
activated  by  Ras  and then  triggers  a  protein  kinase  cascade,  leading  to  the  activation  of 
MAPKs. MAPKs can phosphorylate and inactivate Raf in a negative feedback mechanism 
(Dougherty  et  al.,  2005).  Pin1  prevents  Raf  kinase  from  being  turned  off  after  growth 
stimulation by promoting dephosphorylation of Raf (which is inhibited by phosphorylation) 
probably as a result of the conformational specificity of the phosphatases involved. 
In addition, Pin1 is transcriptionally regulated by the E2F family of transcription factors in 
response to growth factors and other stimulating conditions such as activation of Her2/Neu or 
Ras (Ryo et al., 2002). This suggests the existence of a positive feedback loop, in which Her2/
Neu or Ras activation leads to an increase in Pin1 via E2F-mediated transcription, and Pin1 in 
turn positively regulates cyclin D1 function at the transcriptional level and also through post-
translational stabilization. 
Despite the multitude of molecules that are affected by Pin1-mediated prolyl isomerization, 
and despite the diverse mechanisms it modulates, the common denominator for Pin1 activity 
in cancer cells seems to be the amplification of pro-proliferative signalling at the level of 
proline-directed phosphorylation. A recent study has provided the first genetic data on the role 
of Pin1 in cancer development in vivo (Wulf et al., 2004). Pin1-deficienct mice are largely 
protected from breast cancer induced by oncogenic c-Neu or v-Ha-Ras, but not by c-Myc 
(Wulf et al., 2004), as is the case for cyclin-D1-null mice (Yu et al., 2004), demonstrating an 
essential role for Pin1 in tumorigenesis that is induced by certain oncogenes (Figure 11). 
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Figure 11. Pin1 regulates phosphorylation signalling following phosphorylation
The left part of the figure shows that Pin1 regulates c-Jun stability upon MAPK/JNK phosphorylation. In the middle; Pin1 
regulates beta-catenin, cyclin D1 and NF-kB. Pin1 is an E2F target gene, This suggests the existence of a positive feedback 
loop, in which Her2/Neu or Ras activation leads to an increase in Pin1 via E2F-mediated transcription, and Pin1 in turn 
positively regulates cyclin D1 function.
The rigth  part  of  the  figure  shows that  Pin1 can increase the nuclear  localization and protein half-life  of  p53,  thereby 
involving cell-cycle arrest and apoptosis. Adapted from Wulf et al.,2005.
1.4.7 Pin1 regulation
Pin1 function is tightly regulated by multiple mechanisms under normal growth conditions 
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and  during  the  cell  cycle.  One  such  mechanism  is  inhibitory  phosphorylation  on  sites 
including Ser 16 at the centre of the pSer/Thr-Pro-binding pocket of the WW domain (Lu et 
al., 2002). This phosphorylation abolishes the ability of Pin1 to interact with its substrates. 
Interestingly, Pin1 seems to be hypophosphorylated in breast cancer, suggesting that Pin1 is 
overexpressed  and  also  activated  during  oncogenesis.  Although  protein  kinase  A  can 
phosphorylate Pin1 in vitro, it remains unclear as to which are the physiological kinases and 
phosphatases that regulate Pin1 phosphorylation in vivo. 
Moreover,  it  is  reported  that  the  human  Pin1 binds  to  Plk1  from mitotic  cell  extracts  in 
vitro(Eckerdt et al., 2005). It was demonstrate that Ser-65 in Pin1 is the major site for Plk1-
specific  phosphorylation,  and  the  polo-box  domain  of  Plk1  is  required  for  this 
phosphorylation.  Interestingly,  the  phosphorylation  of  Pin1  by  Plk1  does  not  affect  its 
isomerase activity but rather is linked to its protein stability. Pin1 is ubiquitinated in HeLa S3 
cells,  and substitution  of  Glu for  Ser-65 reduces  the ubiquitination  of  Pin1.  Furthermore, 
inhibition of Plk1 activity enhances the ubiquitination of Pin1 and subsequently reduces the 
amount  of  Pin1  in  human  cancer  cells.  Since  previous  reports  suggested  that  Plk1  is  a 
substrate of Pin1, our work adds a new dimension to this interaction of two important mitotic 
regulators.
2. AIM
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Increasing  evidences  provided  by  several  groups  have  shown that  deregulated  Notch1  is 
involved in  human breast  cancer.  For  example  down-regulation  of  Numb,  that  negatively 
regulates Notch1, has been observed in about 50% of breast carcinomas (Pece et al., 2004). 
Furthermore, Notch1 cross-talks with several pathways that are subverted in Breast Cancer 
such as Ras, Wnt, c-Myc, suggesting that Notch could be a target for drug-based therapy of 
breast  cancer  (Miele  et  al  .,  2006). Expression  of  Notch1  and  Ras  correlates  in  breast 
carcinomas and Notch1 signaling is induced by the MAPK/SAPK pathway upon oncogenic 
Ras activation (Weijzen et al., 2002). 
Phosphorylation-specific  prolyl-isomerizzation  catalyzed  by  the  prolyl-isomerase  Pin1  has 
recently emerged as a potent signal transduction mechanism of several pathways. Pin1 has 
been shown to be involved in several   human malignancies  and in breast  cancer  through 
modulation of a  multiplicity of pathways.  Alteration of Pin1 have been implicated in the 
amplification  of  oncogenic  signals  (Yeh  et  al.,  2007) and  cooperates  with  the  Neu/Ras 
pathway in mammary tumorigenesis (Wulf et al., 2004). 
Based on these data the aim of my thesis was to unveil a possible role of Pin1 in regulation 
the Notch1 pathway and in particular in breast cancer.
3. RESULTS
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3.1 Pin1 interacts with human Notch1 
Since  Pin1  binds  phosphoSerine/Threonine-Proline  sites,  first  of  all  we  tested  if  human 
Notch1 (NP_060087) contains these motifs. Indeed, the cytoplasmic region of Notch1 harbors 
many Ser/Thr-Pro motifs, whose phosphorylation might generate binding sites for Pin1. By 
using  SkBr-3,  MDA-MB-468  and  MCF-7  human  breast  cell  lines  Notch1  was 
immunoprecipitated and probed with MPM-2 antibody that recognizes this kind of sites. This 
experiment showed that endogenous Notch1 is phophorylated in Ser/Thr-Pro motifs (Figure 
1a).  Notably  in  this  experiment  we used  an  antibody  that  recognizes  the  transmembrane 
subunit of Notch1 protein (N1TM). This subunit of the Notch heterodimer contains a short 
extracellular  domain,  the  membrane-spanning  region,  and  an  intracellular  domain  termed 
N1ICD. The extracellular subunit has not been considered.
To verify if Pin1 binds endogenous Notch1 protein same lysates (as in immunoprecipitation 
assay) were subjected to GST or GST-Pin1 pull-down followed by anti-Notch1 Western blot. 
Consistently, endogenous Notch1 present in these cells bound to GST-Pin1 but not to GST 
(Figure 1b). This interaction required a functional Pin1 binding domain because GST-Pin1 
mutans  impaired  for  binding  GST-Y23A,  GST-PPiase)  did  not  bind  endogenous  Notch1 
protein in GST-pull down assay (Figure 1c).
Furthermore this interaction relied entirely on phosphorylation, as demonstrated by the lack of 
binding upon treatment of cell lysates with phosphatase (Figure 1d). Moreover, the interaction 
between Notch1 and Pin1 occurs  in vivo among endogenous proteins as shown by Western 
blot analysis of anti-Notch1 or anti-Pin1 co-immunoprecipitates from SKBr-3 cells (Figure 
1e). Finally to evaluate if the binding between these two proteins is direct we performed a 
Far-western assays. To this end, we utilized a membrane-tethered Notch1 derivative (N1DE) 
that is constitutively processed by gamma-secretase since it lacks most of the extracellular 
domain  (Schroeter et al.,  1998). To performe the experiment with this membrane tethered 
N1DE we used the gamma secretase inhibitor  (GSI) DAPT during the whole experiment. 
Control  or  anti-Flag  antibody  immunoprecipitates  from  pcDNA3-N1DeltaE-FLAG 
transfected SKBr-3 cells (GSI-treated), were subjected to Far Western using purified GST-
Pin1 as a probe. Western Blot analysis with an anti-Pin1 antibody shown that the binding 
between endogenous Notch1 and Pin1 is direct (Figure1f).
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Figure 1. Pin1 binds to human Notch1
a) Endogenous Notch1 is phophorylated in S/T-P sites. Control antibody- (Ctrl) or anti-Notch1 immunoprecipitates (IP) from 
indicated cells were probed with anti-MPM-2 in Western blot (WB) followed by stripping and anti-Notch1 Western analysis 
to show immunoprecipitated protein.  b) Notch1 binds to Pin1. Same lysates as in (a) were subjected to GST or GST-Pin1 
pull-down followed by anti-Notch1 Western blot. Input lane shows 5% of total lysate. c) Schematic of full length GST-Pin1 
and its truncation or point mutants GST pull-down of lysate from SKBr-3 cells was performed incubating with GST, GST-
Pin1 or the indicated GST-Pin1 mutants, followed by anti-Notch1 Western blot. d) GST-Pin1 or GST pull-down experiments 
were performed using mock- or lambda phosphatase treated lysates from SKBr-3 cells, followed by anti-Notch1 immunoblot. 
e) Notch1 and Pin1 interaction occurs  in  vivo.  Western blot  analysis  of  control  antibody,  anti-Notch1 or  anti-Pin1  co-
immunoprecipitates  from  SKBr-3  cells.  f) Notch1  and  Pin1  interaction  is  direct. Control  or  anti-Flag  antibody 
immunoprecipitates from GSI-treated, pcDNA3-N1E-FLAG transfected SKBr-3 cells, were subjected to Far Western using 
purified GST-Pin1 as a probe, followed by anti-Pin1 immunoblot. Anti-Notch1 Western analysis of the upper panel after 
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3.2 Pin1 positively modulates Notch1 transcriptional activity
After  the  binding  evidence  we asked wheter  Pin1 was able  to  modulate  Notch  signaling 
pathway, by analyzing the transcriptional activity of Notch1 in luciferase reporter assays. 
SKBr-3 were transfected with the pcDNA3-N1DeltaE-FLAG plasmid to express N1DE. Since 
N1DE  is  constitutively  processed,  it  releases  active  intracellular  domain  (N1ICD)  that 
translocates  to  the  nucleus  where  it  acts  as  a  transcriptional  transactivator  (Table  1). 
Luciferase reporter assays were performed with the Notch1 target promoter HES-1 (Jarriault 
et al., 1995)  and with a  TK-renilla plasmid as control for the transfection  efficiency.  Co-
transfections experiments in SKBr-3 cells showed that over expression of wild-type Pin1, but 
not a catalytically inactive Pin1 mutant Pin1-S67E (Zhou et al.,  2000), could enhance the 
transcriptional activity of N1DE (Figure 2a). Notably, overexpression of wild-type Pin1 and 
the  catalitic  inactive  Pin1  mutant  does  not  increase  the  luciferase  activity  of  HES-1/Luc 
indicating that the effect of Pin1 is Notch1 dependent (Figure 2a). Importantly, GSI treatment 
confirmed a specific function of Pin1 on Notch1 pathway.On the other hand, either ablation of 
Pin1  expression  by  RNA  interference  (RNAi)  or  inhibition  of  its  activity  by  the  small 
molecule inhibitor PiB (Uchida et al., 2003), significantly reduced the transcriptional activity 
of N1DE on experiments  performed as above (Figures  2b,  2c).  Together  the binding and 
luciferase assays indicate that Pin1 interacts with human Notch1 and regulates its function 
through its prolyl-isomerase activity. 
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Table 1.  Constructs used
Notch1  derivates   N1DE,  N1ICD  forms  and  the  epitope  recognized  by  the  antibody  used.  Note  that  NICD  antibody 
recognizes the gamma-secretase product N1ICD, whereas the anti-myc and anti-Notch1 antibodies recognize all the forms. 
Figure 2. Pin1 affects Notch1 activity
a)  Pin1 affetcs Notch1 transcriptional activity.Luciferase assay in SKBr-3 cells co-transfected with pGL2HES-1/LUC and 
N1DE expression vector (pcDNA3-N1DE-Flag). Expression vectors for either wild-type (HA-Pin1) or catalytically inactive 
(HA-S67E)  Pin1  were  co-transfected,  with  gamma-secretase  inhibitor  (GSI),  where  indicated  (grey  bars).  Histograms 
represent means and s.d. of at least three independent experiments;  b) Specific knock down of endogenous Pin1 affects 
Notch1 transcriptional activity. Transcriptional activity of N1DE was tested on HES-1/LUC in SKBr-3 cells in presence of 
either a Pin1 specific (RNAi Pin1) or control siRNA (RNAi C). c) Pin1 inhibitor (PIB) reduces N1E transcriptional activity. 
Luciferase assay of SKBr-3 cells co-transfected with HES-1/LUC and pcDNA3-N1E-Flag and treated with PIB or vehicle. 
Histograms represent means and s.d. of at least three independent experiments. a)-c) P values are indicated for the observed 
differences and cell lysates were analyzed by Western blot.
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3.3 Pin1 co-localizes with N1DeltaE in the membrane compartment
We next performed a confocal immunofluorescence analysis of Pin1 and N1DE in SKBr-3 to 
evaluate the subcellular localization  of both proteins. Cells were transfected with pcDNA3-
N1DeltaE-myc and treated with GSI to keep N1DE uncleaved in the membranes. As shown in 
Figure  3  NDE  and  Pin1  co-localize  at  the  cell  membrane  compartment  before  gamma-
secretase cleavage either with overexpressed Pin1 (oe Pin1) or endogenous Pin1 (end.Pin1). 
Figure3. Pin1 co-localizes with N1DE
Confocal  immunofluorescence  analysis  was  performed  on  SKBr-3  cells  overexpressing  myc-tagged  N1DE (green)  and 
endogenous  (end.)  or  overexpressed  (oe)  Pin1 (red)  in  presence  of  GSI.  The white  arrows  indicate  the  co-localization 
between NDE and Pin1
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3.4 Pin1 affects Notch1 processing by gamma-secretase 
To understand the role of Pin1 in modulating Notch signaling we tested its role in perturb 
Notch1 processing. To this end we transfected SKBr-3 cells with pcDNA3N1DE-FLAG and 
with two different siRNAs for Pin1. As shown in Figure 4a and 4b knock-down of Pin1 with 
siRNA, in N1DE-transfected cells, resulted in decreased levels of processed N1ICD .
We  next  analyzed  the  effects  of  Pin1  over-expression  on  the  processing  of  endogenous 
Notch1, by measuring the amount of NICD produced upon a short treatment with EDTA in 
culture (Figure 4c). This treatment has been shown to trigger Notch1 cleavage by gamma 
secretase (Rand et al., 2000) and it is blocked by GSI. Ablation of Pin1 expression by RNA 
interference (RNAi), reduced Notch1 cleavage after EDTA treatment in SKBr-3 (Figure  4c). 
This  effect  was  not  dependent  on  changes  in  active  presenilin  levels  upon  Pin1 
overexpression,  as  judged  by  Western  blot  against  N-  and  C-terminal  fragments  of 
presenilin-1 (NTF and CTF) that consist the core of the gamma-secretase enzyme (Figure 4c). 
To  confirm  these  data  we  over-expressed  HA-Pin1,  by  retroviral  infection,  in  human 
MCF-10A. After the infection we selected a stably expressing NDE population of MCF-10A 
cells (polyclonal) and we performed the same experiment as above. As shown in Figure 4d in 
these  cells  the  efficiency  of  endogenous  Notch1  processing  triggered  by  EDTA  clearly 
increased compared with empty vector infected cells. 
Finally,  we measured the EDTA-induced processing of endogenous Notch1 in  Pin1+/+ and 
Pin1-/-  primary Mouse Embryo Fibroblasts (MEFs)  (Fujimori et al., 1999). Lower levels of 
NICD were detected  in  Pin1-/- compared  to Pin1+/+ cells  (Figure 4e).  Importantly,  Notch1 
processing  could  be  completely  rescued  in  Pin1-/- MEFs  upon  re-introduction  of  Pin1 
expression (Figure 4e), suggesting that the observed effect was dependent on Pin1 expression. 
We next analyzed wheter the reduced cleavage of Notch1 was due to a diminished binding of 
Notch1 to presenilin.  Performing Co-IP experiments in MEFs  Pin1+/+ and  Pin1-/- we have 
found that there are no binding differences between these two proteins (data not shown).
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Figure 4. Pin1 affects human Notch1 processing by gamma-secretase
a-b) Ablation of Pin1 impairs constitutive processing of N1DE. Western blot analysis of N1DE-Flag processing in SKBr-3 
cells transfected with control (RNAi C) or Pin1 specific siRNA (RNAi Pin1) and treated with vehicle or GSI. c) Ablation of 
Pin1 impairs Notch1 cleavage, by gamma-secretase SKBr-3 cells were left untreated (–) or activated with EDTA, or EDTA 
and GSI as control (Rand et al., 2000). d) Pin1 overexpression enhances Notch1 cleavage by gamma-secretase. Western blot 
analysis of endogenous Notch1 processing from MCF-10A cells infected with pLPC (vector) or pLPC-HA-Pin1 and left 
untreated (–) or activated with EDTA, or EDTA and GSI as control (Rand et al., 2000). Black arrows show migrations of 
endogenous Pin1 (lower arrow) and overexpressed HA-Pin1 (upper arrow). e) Notch1 processing decreases in Pin1-/- MEFs 
and is rescued by reintroduction of Pin1. Pin1+/+ and  Pin1-/- MEFs were mock treated or treated with EDTA as above. In 
parallel, the same experiment was performed with Pin1-/- MEFs infected with a Pin1 retroviral expression vector (pBabe-Pin1 
a)-d) Molecular weight standards are indicated in KDa. 
a)-e) Densitometric recording of cleaved (N1ICD) and uncleaved (N1DE or Notch1 untreated) protein levels was performed 
by Image J software and the ratio between N1ICD and the corresponding uncleaved form, was calculated. The mean values 
of the ratios (percentage)  from three independent experiments  were  compared,  setting control  ratio  average  to  100% ± 
standard deviations, and are shown in the graphs, and P values for the observed differences are indicated.
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3.5 Pin1 enhances Notch1 processing by binding to the STR region 
To start  dissecting  the  mechanism by  which  Pin1  promotes  Notch1  processing,  we  then 
mapped the Pin1-interacting domains on Notch1. 
To this end, several N1DE deletion mutants were generated (Figure 5a), over-expressed in 
HEK 293T cells in the presence of GSI, and tested for binding to GST-Pin1(WW) in vitro. As 
shown in Figure 5b, C-terminal truncation of N1DE deleting the PEST domain (dP) led to a 
decreased  binding to  Pin1,  that  was  further  reduced upon deleting  also the  TAD domain 
(d2171).  The  interaction  was  abolished  in  d2120  upon  further  removal  of  the  Serine-
Threonine-rich region STR (Ingles-Esteve et al., 2001). Lack of STR alone also reduced the 
interaction of Pin1 to both, N1DE and N1DE-dPest (dSTR, dP-dSTR). 
These experiments reveal that Pin1 binds the Notch1 protein in three domain, the STR, OPA 
and the PEST domain.
To identify which of the Pin1-interacting regions were important for Notch1 cleavage, we 
tested the processing efficiency of all deletion mutants upon over-expression in SKBr-3 cells. 
We could observe that only those mutants lacking the STR region (d2120, dSTR, dSTR-dP) 
showed a reduced cleavage as compared to N1DE or to mutant d2171, which contain the STR 
region (Figure 5c-d). 
The above results might suggest that Pin1, upon binding to the STR region, could produce a 
conformational change leading to proficient cleavage of Notch1 by gamma-secretase. 
The STR region contains four Ser/Thr-Pro motifs, which are putative MAPK targets. Indeed 
we observed that the binding of d2171 to GST-Pin1(WW) was reduced by treatment of intact 
cells with inhibitors of MEK/Erk or JNK (Figure 5e). Thus, we mutated these putative Pin1-
binding sites by Ser/Thr to Ala substitutions in construct d2171 (d2171-4M), and observed a 
reduction  of  binding  to  Pin1 (Figure 5f).  Importantly,  mutation  of  these Pin1 target  sites 
reduced the efficiency of d2171 processing by gamma-secretase as shown in Figure 5g. 
Notably, these mutations rendered the cleavage insensitive to Pin1 over-expression (Figure 
5h). All these data suggest that conformational changes of the STR region upon Pin1 binding 
are necessary for an efficient cleavage by gamma-secretase. 
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Figure 5. Pin1 improves cleavage of human Notch1 by binding to the STR region
a)  Schematic  of pBabe-N1DE-myc  deletion  constructs  used  in  experiments  in  (b).  TM:  transmembrane,  RAM:  CSL 
interacting, ANK: ankyrin,  STR: Ser/Thr rich, TAD: transactivation, PEST: Pest domain. Numbering refers to Swissprot 
entry P46531. Interactions with Pin1 (b) are indicated next to the constructs; +++ strong, ++ intermediate, + weak, – no 
binding. b) Mapping of Pin1 binding domains of Notch1. Constructs shown in (a) were over-expressed in HEK 293T cells, 
treated with GSI and lysates subjected to GST-Pin1(WW) or GST (not shown) pull down assay, followed by Western blot 
with anti-myc antibody. Molecular weight standards are indicated in KDa. c-d) N1DE proteins lacking STR are impaired in 
processing. Cleavage of N1DE deletion mutants was analyzed by Western blot upon over-expression in SKBr-3 treated with 
either GSI or DMSO. Upper panels show uncleaved inputs (GSI treated), while in the lower panels the cleavage product 
recognized by the Val 1744 antibody (N1ICD) is shown. N1ICD and N1DE protein levels were recorded as in Figure 2 and 
the ratio (percentage) between N1ICD (cleaved) and the corresponding uncleaved form is shown in the diagram. The ratio of 
N1DE-d2171 and N1DE FL were set  to 100% ± standard deviations.  The mean values  of the ratios from at least three 
independent experiments were compared, and P value for the observed difference is indicated. d) Interaction of Pin1 with the 
STR region is impaired by MAP/SAPK inhibitors. Schematic of STR domain showing S/T-P motifs (bold). pBabe-d2171-
myc was tested for Pin1 binding as in (b) either in absence (-) or presence of indicated kinase inhibitors. e) Mutation of S/T-P 
motifs  in STR (d2171-4M) impairs binding to Pin1. Constructs pcDNA3-d2171-4M-myc and pcDNA3-d2171-myc  were 
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tested for Pin1 binding as in (b). f) Mutation of S/T-P motifs in STR (d2171-4M) impairs processing by gamma-secretase. 
pcDNA3-d2171-myc or pcDNA3-d2171-4M-myc were overexpressed in SKBr-3 cells and their processing analyzed as in 
(c).  g) Absence of S/T-P sites in the STR region of Notch1 hampers Pin1-dependent increase of processing by gamma-
secretase.  Comparable  amounts  of  d2171 or  d2171-4M were  over-expressed  in  Pin1-/- fibroblasts  along with  increasing 
amounts of Pin1 and processing was then analyzed as in (c). 
3.6 Pin1 potentiates Notch1 transforming activity
The role of Pin1 in potentiating Notch1 signaling prompted us to investigate the impact of 
Pin1 on Notch1 transforming activity. To this aim we decided to perform a soft agar assay in 
the immortalized normal mammary cell line MCF-10A. N1DE was over-expressed in these 
cells either alone or together with HA-Pin1, and cells were then tested for the ability to grow 
in soft agar. Consistent with previous reports,  (Stylianou et al., 2006) activated Notch1 was 
able  to  sustain  anchorage-independent  growth  of  these  cells  (Figure  6a),  while  ectopic 
expression  of  Pin1  alone  could  not  induce  the  formation  of  colonies  in  soft  agar,  it 
significantly increased the colony-forming efficiency of N1DE, when over-expressed together 
(Figure 6a). This was not observed in the presence of GSI, thus confirming that the effect of 
Pin1 required Notch1 activity. Soft-agar assays were also performed in MCF-10A cells stably 
infected with a vector expressing a Pin1-specific short harpin RNA(shRNA) to down-regulate 
Pin1.  Importantly,  ablation  of  Pin1  by  shRNA could  block  soft  agar  growth  induced  by 
N1DE, suggesting that Pin1 is required for Notch1-induced cell transformation (Figure 6a).
Western blot analysis  of N1DE expressing clones used in these experiments revealed that 
Pin1-specific shRNA led to a decrease in the levels of both cleaved Notch1 and of the Notch1 
target Hes-1 (Figure 6b, compare lanes 5 and 4). On the other hand, Pin1 over-expression in 
N1DE infected  MCF-10A clones  enhanced  the  levels  of  both  cleaved  Notch1 and Hes-1 
(Figure  6b,  compare  lanes  5  and  6).  Confirming  our  previous  data,  that  Pin1  modulates 
Notch1 pathway activation by increasing N1ICD production and endogenous protein levels of 
Hes-1. 
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Figure 6. Pin1 impacts on human Notch1 transforming activity
a) Notch1  transforming  activity  is  modulated  by  Pin1.  Normal  MCF-10A breast  epithelial  cells  were  transduced  with 
retroviruses encoding N1DE-Flag along with empty (grey bars) or HA-Pin1 (black bars) expressing vectors and grown in soft 
agar  with  or  without  GSI  treatment.  In  parallel,  downregulation  of  Pin1  was  assayed  by  co-infection  of  N1DE-Flag 
expressing cells with Pin1 specific (Pin1)(white bars) or control (C) shRNA encoding vectors. After 3 weeks colonies were 
counted. Histograms represent means and s.d. of three independent experiments, with P values for the observed difference 
between N1DE and N1DE with either HA-Pin1 or RNAi Pin1, are indicated. Representative phase contrast images of soft 
agar colonies of the indicated clones are shown in the lower panel. b) Protein lysates were analyzed in Western blot (except 
from GSI treated colonies), arrows indicate endogenous (lower) and over-expressed (upper) HA-Pin1, respectively. c) and d) 
middle panels show Western analysis of protein lysates and lower panels show representative phase contrast images of the 
above colonies.
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3.7 Pin1 is a novel Notch1 target gene
In  the  above  experiments,  we  consistently  observed  higher  levels  of  endogenous  Pin1 
expression in cells stably expressing N1DE as compared to vector-transfected cells (Figure 
6b, compare lanes 2 and 5, and Figure 6c, compare lanes 1 and 3). Notably, these increased 
Pin1 levels  could be reversed by treatment  with GSI,  similarly to  the Notch1-target  gene 
HES-1 (Figure  6c,  compare  lanes  3  and 6).  This  evidence  prompted  us  to  investigate  if 
Notch1 could perturb endogenous Pin1 expression. 
To  test  whether  Notch1  induces  Pin1  at  the  transcriptional  level,  we  performed  semi-
quantitative  RT-PCR  from  MCF-7  cells  over-expressing  N1ICD  and  we  observed  an 
increased Pin1 mRNA level compared to the vector-transfected cells (Figure 7a). As control 
we checked the mRNA levels of the Notch1 target Hes-1 (Figure 7a).
Moreover  H1299  cells  expressing  N1ICD-ER  fusion  protein  (Ronchini  and  Capobianco, 
2000) demonstrated that,  upon induction of N1ICD nuclear translocation by 4-OHT, Pin1 
mRNA levels raised, similarly to those of Notch targets Hes-1 and Hey-1 (Maier and Gessler, 
2000) (Figure  7b).  These  results  are  consistent  with  the  presence  of  three  putative  CSL-
binding sites within the human Pin1 promoter, that are partially conserved also in the mouse 
gene (Figure 7c). We therefore cloned the human Pin1 promoter upstream of the luciferase 
gene, and demonstrated that its activity could be specifically induced by over-expression of 
N1DE (Figure 7c). 
Finally  to  establish  if  N1ICD associates  with  the  human  Pin1  promoter  we performed  a 
chromatin  immunoprecipitation (ChiP)  in  HEK  293T  cells.  After  cromatin 
immunoprecipitation with an anti-Notch1 antibody we amplified the DNA with two pairs of 
primers, covering the Pin1 promoter region containing the two distal CSL-binding sites (BS1) 
and the proximal one (BS2) respectively. 
 This analysis demonstrated that only the two distal BS1 on the endogenous Pin1 promoter 
were specifically bound by N1ICD (Figure 7d), while no chromatin association was detected 
upon GSI treatment. 
These data confirm that Pin1 is a new direct target of Notch1
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Figure 7. Pin1 is a novel transcriptional target of human Notch1
a) N1ICD enhances Pin1 mRNA levels. RT-PCR analysis of the indicated genes from MCF-7 cells stably transfected with an 
empty or N1ICD expressing vector. b) N1ICD activation enhances Pin1 mRNA levels. RT-PCR analysis of Pin1, HES-1 and 
Hey-1 in H1299 cells stably expressing ER-N1ICD after 24 hours of mock (EtOH) or 4-OH-tamoxifen (OHT) induction. a) 
and b) Human  GAPDH has been included for normalization.  c) Notch1 activates the human Pin1 promoter. (upper part) 
Schematic of human Pin1 promoter (genomic sequence from -713 to +53 with respect to the ATG) depicting CSL binding 
sites and indicating the primer sets used for ChIP analysis in (d). The depicted genomic region of the human Pin1 promoter 
was  PCR  amplified  and  cloned  into  pGL3/LUC.  (lower  part)  Reporter  assays  of  pGL3hPin1/LUC  upon  N1ΔE-Flag 
expression in SKBr-3 cells in presence (grey columns) or absence (black columns) of GSI. Histograms represent means and 
s.d. of at least three independent experiments. Cell lysates were analyzed by Western blot.  d) Notch1 associates with the 
human  Pin1  promoter. Binding  of  endogenous  N1ICD  to  the  human  Pin1  promoter,  analyzed  by  Chromatin 
Immunoprecipitation  analysis  in  HEK 293T cells,  treated either  with  DMSO or  GSI,  is  shown.  Semi-quantitative  PCR 
analysis of Pin1 promoter (sequences BS1 and BS2) or HES-1 promoter as positive control (C+) or HES-1 intron (Fryer et 
al., 2004) as negative control (C-) were performed on -Notch1 or unrelated (-HA) chromatin immunoprecipitates. 
3.8 Expression of Pin1 and activated Notch1 (N1ICD) correlates in human breast cancer
Next we analyzed the levels of the Notch1 targets Pin1 and Hes-1 in several breast tumor cell 
lines of lobular (SkBr-3, MCF-7) and ductal (MDA-MB-468, MDA-MB-435, MDA-MB-231) 
origin, known to have deregulated Notch activity (Stylianou et al., 2006). 
All these cell lines showed high levels of both HES-1 and Pin1 as compared to the normal 
human mammary MCF-10A cell line (Figure 8a). 
These results suggested a cross-talk between Pin1 and Notch1 in breast carcinogenesis. We 
sought for evidence, in primary breast cancers, that could corroborate this possibility. To this 
end, we performed immunohistochemical analysis of Pin1 and N1ICD expression on serial 
sections from the same breast tumor tissue microarrays (in collaboration with Pier Paolo di 
Fiore,  Salvatore  Pece  and  Paolo  Nuciforo,  IFOM  Milan).  This  analysis  highlighted  a 
significant direct correlation between Pin1 expression levels and accumulation of N1ICD in 
these tumors (Figures 8b, 8c): those tumors exhibiting high levels of nuclear N1ICD (59 out 
of 147) showed also high Pin1 protein levels in the majority of the cases (65%), while low 
levels of N1ICD  (88 out of 147) were paralleled by low levels of Pin1 (85%). 
Similar results were obtained when the expression levels of the downstream Notch target gene 
HES-1  were  analyzed  by  immunohistochemistry  on  the  same  tissue  microarrays  and 
compared to Pin1 expression (Figure 8b, 8c).
This correlation between N1ICD and Pin1 protein levels  in human breast  cancer  samples 
supports our hypothesis of a possible positive loop between these two proteins that could be 
relevant for human carcinogenesis.
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Figure 8. Expression of Pin1, Notch1 and HES-1 in breast cancer cell lines and in serial 
sections of breast carcinoma samples 
a) Western Blot analysis of a human immortalized breast cell line (MCF-10A) and five breast cancer cell lines (MCF-7,Sk-
Br3, MDA-MB-468, MDA-MB-435, MDA-MB-231) is shown for Notch1, Pin1 and HES-1, normalized by actin levels. b) 
Representative samples showing immunohistochemical analysis of breast tissue microarrays performed with the indicated 
antibodies on adjacent sections of the same array. (1-3) An example of breast carcinoma negative for all three proteins; (4-9) 
examples of moderate to strong expression for N1ICD, Pin1 and HES-1 on two different breast cancer samples  c) Graphs 
showing correlation between Pin1, HES-1 and N1ICD expression levels in breast cancer. P values of observed differences, 
according to pearson chi-square, are indicated.
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4. DISCUSSION
Cancers arise as somatic cells mutate and escape the control of cell cycle, survival or death. 
These processes are normally regulated by several signalling pathways and recently several 
studies highlight the potential importance of the Notch1 signaling pathway in human cancer. 
Notch activation has been involved in several mouse models of mammary carcinogenesis and 
recently  also  in  human  breast  cancer.  Importantly  loss  of  Numb,  a  negative  regulator  of 
Notch1, has been observed in about 50% of breast carcinomas (Pece et al., 2004). 
Expression of Notch1 and Ras correlates in breast carcinomas and expression of the Notch1 
pathway ligand Jagged1 is a potential markers for breast cancer progression (Reedijk et al., 
2005). Furthermore, the Notch1 interplay with pathways such as Wnt, c-Myc, is subverted in 
breast cancer, thus suggesting that Notch could be a target for drug-based therapy of breast 
cancer . Intriguingly  also the prolyl-isomerase Pin1 is crucial in breast cancer and in several 
human malignancies through modulation of these pathways. Alterations of Pin1 have been 
implicated in the amplification of oncogenic signals, as demostarted by its cooperation with 
the Neu/Ras pathway in mammary tumorigenesis (Wulf et al., 2001) . 
The  aim of  this  work  was to  unveil  a  possible  role  of  Pin1  in  the  regulation  of  Notch1 
pathway in breast cancer.  Pin1 directly interacts with phosphorylated Notch1, and increases 
Notch1 cleavage by gamma-secretase. Accordingly, Pin1 contributes to Notch1 transforming 
properties in human breast cells. Notch1 in turn up-regulates Pin1, thus establishing a feed-
forward  loop that  amplifies  Notch1  signalling.  Importantly  human  breast  cancers  bearing 
elevated levels of Pin1 have also deregulated expression of activated Notch1 and Hes-1 and 
these data underscore the relevance of our observations for human carcinogenesis.
The increasing evidence that Notch signalling can drive the growth of a wide range of tumors, 
from leukaemia to breast cancer, has recently promoted intense studies of the mechanisms 
that lead to alteration of this pathway during carcinogenesis . Several crucial aspects however 
remain  obscure,  in  particular  concerning  the  regulation  of  Notch1 activation  and how its 
downstream  effects  contribute  to  the  neoplastic  phenotype.  One  critical  point  in  Notch 
activation  entails  proteolytic  cleavage  by  gamma-secretase, but  several  mechanisms  that 
impinge on this step are still elusive .
- The results presented in this thesis have shown that, in addition to the extracellular domain 
of the receptor, also the intracellular serine/threonine rich (STR) region of Notch1 may be 
required for efficient processing. This region is conserved between Notch1 and Notch2 and 
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has been shown to be phosphorylated in response to cytokine-induced differentiation of 32D 
cells . 
These  results,  obtained  by  mimicking  Notch1  activation  by  EDTA  treatment  or  ectopic 
expression of constitutively cleaved N1DE, allow us to hypothesize that Pin1 binds to critical 
Ser/Thr-Pro sites within STR upon phosphorylation, producing a conformational change of 
Notch1, that favors processing by gamma-secretase. Indeed, we have shown that deletion of 
this region, or mutation of the critical phosphorylation and Pin1 binding sites, dramatically 
impairs the constitutive processing of N1DE. Notably, the cleavage of this Notch1 mutant is 
insensitive to Pin1 over-expression. 
These  effects  were  not  dependent  on  changes  in  active  presenilin  levels  upon  Pin1 
overexpression,  as  judged  by  Western  blot  against  N-  and  C-terminal  fragments  of 
presenilin1.
All these data support the hypothesis that  conformational changes of the STR region upon 
Pin1  binding  are  necessary  for  an  efficient  cleavage  by  gamma-secretase.  All  these  data 
suggest that Notch1 processing was shown to be strongly increased in Ras-transformed cells . 
The observation  that  Pin1 binding to  Notch1 involves  phosphorylation  events  induced by 
MAPK/SAPKs, coupled with the evidence that Pin1 expression is induced by Ras indicates a 
role of Pin1 in the activation of Notch1 by oncogenic stress. 
Recently  it  was  demostrated,  that  a  monoubiquitination  event  takes  place  on  the  NDE 
molecule, which is constitutively cleaved form of Notch receptor (Gupta-Rossi et al., 2004). 
This  modification  that  occurs  during  endocytosis  seems  to  be  a  prerequisite  for  gamma-
secretase cleavage of NDE, since not monoubiquitinated NDE is less cleaved by gamma-
secretase, but still interact with PS when overexpressed. Therefore it is temping to predict that 
as it  does with activate  Notch at  the membrane,  the complex being then ubiquinated  and 
internalized to reach the endocytic compartment where the gamma-secretase is active. These 
data suggest that ubiquitination could be required for an efficent Notch1 cleavage. We can 
speculate  that  Pin1  could  also  modulate  Notch1  processing  by  influencing  the  mono-
ubiquitination of Notch1 receptor.
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 -  N1ICD  transcription  factor  activates  specific  subsets  of  downstream  targets.  The 
mechanistic  basis  for  such  selectivity  is  not  easily  understood  because  N1ICD  binds  to 
promoters via an interaction with the same protein, CSL. Recent analyses have demonstrated 
that the potency of the four vertebrate NICD in a transient transfection assay depends on the 
promoter, the amino acid composition of the individual Notch proteins, and to a lesser degree 
on a cellular context. Collectively, these data suggest that a matrix of parameters that include 
NICD  concentration,  CBS  (CSL  binding  site)  orientation,  and  promoter  context  will 
determine which promoters respond to a particular Notch protein at a given level of ligand 
binding. Notch signaling is mediated through CBS that can bind to either a low (RTGRGAR) 
or high affinity (YGTGRGAA) CSL. The best characterized Notch target promoter such as 
HES1 in mouse contains a highly conserved "SPS" (Su(H) paired sites (Ong et al., 2006), that 
is composed of two inverted CBS sites (CBS-A and CBS-B) separated by 15-22 nucleotides. 
As reported previously, it was found that intact CBS A and B are necessary for activation of 
the HES1 promoter. In fact, a minimal promoter containing only the paired site and a TATA 
sequence is sufficient to elicit the 60% luciferase activity compared to the HES1 promoter, 
confirming that the SPS is both necessary and sufficient for Notch-dependent gene expression 
in vertebrate cells. The HES5 promoter does not contain paired CBS, instead, it has two high 
affinity CBS located 134 bases apart and three low affinity sites further upstream. Mutating 
the two most proximal high affinity sites abolished Notch-mediated activation. Moreover, also 
N3ICD transactivates  Hes5 and its  activation  depends critically  on a  putative  zinc  finger 
transcription  factor-binding  site  (ZFBS;  GCCGCCATT)  and  a  binding  site  for 
CCAAT/enhancer-binding  protein  alfa  (C/EBPalfa)  undifferentiated  protein  (CUP) 
(CCGCCG). All three sites occupied 27 bases within the HES5 promoter. These observations 
suggest that the zinc fingers TF and possibly CUP are recruited to their putative binding site 
where they act synergistically with the C-terminal region of Notch3. Interestingly,  also the 
human Pin1 promoter contains  three CBS,  two of these sites are located ~700 bp upstream of 
the ATG (CBS-A,CBS-B). These two sites are also conserved in mouse Pin1 promoter. These 
CBS have  a  low and an  high  affinity  for  CSL and are  separeted  by only 4  nucleotides. 
Moreover CBS-A/B are required for the NICD transactivation of the Pin1 promoter and are 
bound  by  N1ICD,  while  the  third  seems  not  to  be  bound  by  N1ICD.  Importantly  Pin1 
promoter has not inverted sites as Hes-1. It remains to be seen if it could be modulated by the 
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 binding  with  other  transcription  factors  as  the  Hes5  promoter  does.  This  aspect  is  very 
important to unveil new transcription factors that synergistically act  with the Notch pathway 
to regulate Pin1 expression. 
- Interestingly Notch1 is also important in several physiological processes and in controlling 
cell fate in normal conditions. In mammals, a wide variety of cells use the Notch signaling 
system for embryonic development and, in adults, maintenance of homeostasis. The Notch 
signaling pathway regulates  intestine  stem cell  self-renewal,  together  with other  signaling 
pathways, such as Wnt and hedgehog. Notch signals are involved in various stem and early 
progenitor cell systems in both the developmental and adult phases. 
Adult stem cells are considered to maintain homeostasis of cells and tissues throughout life. 
The adult stem cells maintain the number of stem cells, as well as terminally differentiated 
cells, during normal turnover and repair damage after injury. Involvement of Notch signaling 
occurs during both normal status and injury in various stem cell systems.     
The mammary gland in humans and in other mammals is a dynamic organ that undergoes 
significant developmental changes during pregnancy, lactation, and involution. It is likely that 
the cellular repertoire of the human mammary gland is generated by a stem cell component.   
Activation of the Notch pathway results in changes in cell fate, including self-renewal of stem 
cells  or  differentiation  along  a  particular  lineage.  The  Notch  pathway  was  shown  to  be 
involved in the normal development of the mammary gland. Interestingly mice  Pin1-/- show 
failure  in  massime  proliferation  of  the  mammary  gland  during  pregnancy.  This  evidence 
suggest  a  possible  role  of  Pin1  in  mammary  stem cell  regulation  by modulating  Notch1 
pathway, or by other cellular pathways. Moreover Pin1 could be involved in the stem cell 
mainteinace of several tissues that required the activation of the Notch1 pathway.
For exanple in hematopoietic stem cell and in  Intestinal epithelial stem/progenitor cells self 
renewal. Indeed, the administration of gamma-secretase inhibitors induces  histologic changes 
in the intestinal epithelial layer of mice, and conditional inactivation of CSL in the epithelium 
of the intestine and colon induces conversion of proliferative crypt cells to postmitotic Goblet 
cells (Searfoss et al., 2003, Wong et al., 2004, van Es et al., 2005). These findings suggest that 
Notch  signaling  in  adults  functions  to  maintain  intestinal  epithelial  stem/progenitor  cells. 
Moreover  Notch1  pathway  cross-talks  with  Wnt  pathway  in  controlling  self-renewal  of 
intestinal  stem  cell,  another  important  cellular  signaling  involved  in  tumorigenesis  and 
modulated  by  Pin1.  Furthermore  Pin1  could  regulates  stem  cell  self  renewal  and 
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 tumorigenesis also in intestine.  
4.1 Conclusion
During  my  thesis  we  have  demonstrated  a  role  for  Pin1  in  enhancing  human  Notch1 
signalling  via  its  prolyl-isomerase  activity.  Pin1 directly  interacts  with  phosphorylated 
Notch1, and increases Notch1 cleavage by gamma-secretase. Accordingly, Pin1 contributes to 
Notch1 transforming properties in human breast cells. Notch1 in turn up-regulates Pin1, thus 
establishing a feed-forward loop that amplifies Notch1 signalling. Importantly,  our finding, 
that human breast cancers bearing elevated levels of Pin1 have also deregulated expression of 
activated  Notch1  and  HES-1,  underscores  the  relevance  of  our  observations  for  human 
carcinogenesis.
By up-regulating Pin1, Notch1 improves its own processing and activation. In addition, Pin1 
might impinge on N1ICD activity and it could also directly affect some Notch1 transcriptional 
targets, such as cyclin D1 and NF-kappaB , further amplifying the Notch1 signal. 
The  relevance  of  this  molecular  circuitry  in  human  carcinogenesis  could  have  important 
implications  for  therapeutic  intervention.  Targeting  gamma-secretase  to  block  Notch1 
signaling is considered a promising strategy for therapy of human cancers, particularly breast 
tumors . However GSIs, although effective  in vitro, exhibit a clear toxic effect due to their 
action on normal stem cells. Here we have shown that Pin1 down-regulation by either RNAi 
or pharmacological means dramatically reverts Notch1 dependent cell growth, with an effect 
comparable to that of gamma-secretase inhibitors (Figure 6). It is therefore tempting to predict 
that in tumors with deregulated expression of both Notch1 and Pin1, a lower dose of GSI 
could provide a better response if administered in combination with Pin1 inhibitors.
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 5. METHODS
Oligonucleotides. All oligonucleotides were purchased from MWG Biotech.
for cloning the  human Pin1 promoter:  
Forward primer 5’-AGGACGTGGAAGGCCTT-3’ (713 bp upstream from ATG)
Reverse primer 5’-GCTGCGGCTCATGCGCT-3’ (53 bp downstream from ATG)
for cloning pBabe-N1DE-myc: 
Forward  primer  5’GAGCGGATCCATGCCGCCGCTCCTGGCGCCCCT-3’  (BamHI  site 
underlined and ATG initiation codon in bold print)
Reverse  primer  5’-CATCCTTCTCGAGCTTGAAGGCCTCCGGAATG-3’  (XhoI  site 
underlined, no  STOP codon, only last aa = E2555 of human Notch1 in bold print).
for construction of pBabe-N1DE-myc deletion plasmids (dP, d2171, d2120, dSTR, dSTR-dP):
At the 5’ end the same forward primer as for pBabe- N1DE-myc was used. 
At the 3’ end the following reverse primers were used:
for dP and dSTR-dP 5’-TGGCTCGAGGTCTGCCTGGCTCGGCTCTCCACTCAGGA-3’, 
for d2171 5’-CTTCTCGAGCTTGCTTCCACAGGCCA-3’, 
for d2120 5’-CGGCTCGAGCACCAGGTTGTACTCGTCCA-3’
for internal truncations in constructs dSTR and dSTR-dP:
reverse primer on aa 2120 (5’-CGGGCTGTCGACCAGGTTGTACTCGT-3’)
forward primer on aa 2175 (5’-GAGGCCGTCGACCTCAAGGCACGGA-3’) 
for construction of d2171-4M:
S2122A forward 5’-AGTACAACCTGGTGCGCGCCCCGCAGCTGCA-3’ 
S2122A reverse 5’-GCGCACCAGGTTGTACTCGTCCAGCA-3’; 
T2133A forward 5’-GAGCCCCGCTGGGGGGCGCGCCCACCCTGT-3’ 
T2133A reverse 5’-GCCCCCCAGCGGGGCTCCGTGCAGCT-3’;  
T2133A/S2137A  forward  5’-
GAGCCCCGCTGGGGGGCGCGCCCACCCTGGCGCCCCCGCTCT-3’ 
T2133A/S2137A reverse 5’- GCCCCCCAGCGGGGCTCCGTGCAGCT-3’
T2133A/S2137A/S2142A forward 5’-TGGCGCCCCCGCTCTGCGCGCCCAACGGCT-3'
T2133A/S2137A/S2142A reverse   5’-GCAGAGCGGGGGCGCCAGGGTGGGCGC-3’.
for generation of pcDNA3-HA-Pin1-S67E by site-directed mutagenesis:
Forward primer 5’- CTGGCTGTGCTTCACCAGCAGGTGCGAGCAG-3’
Reverse primer 5’-AGGGCCGCCGTTCCTGGCTGTGCTTCACCAGCA-3’
for RT-PCR: 
HES-1 forward: 5’-GAGAAAAGACGAAGAGCA-3’
HES-1 reverse: 5’-TGTGCTCAGCGCAGCCGT-3’ 
HEY-1 forward: 5’-GAGGTGGAGAAGGAGAGTGC-3’  
HEY-1 reverse: 5’-CTCCGATAGTCCATAGCAA-3’   
PIN1 forward: 5’-CATCACTAACGCCAGCCAGT-3’ 
PIN1 reverse: 5’-TCAAATGGCTTCTGCATCTG-3’ 
GAPDH forward: 5’-GCCAGTGGACTCCACGAC-3’ 
GAPDH reverse: 5’-CAACTACATGGTTTACATGTTC-3’ 
for silencing:
71
 siRNA Pin1(I) 5’-GCCAUUUGAAGACGCCUCG-3’ 
siRNA  Pin1(II)  5’-CGGGAGAGGAGGACUUUGA-3’  (upgrade  7  from  smart  pool, 
Dharmacon)
siC(I) 5’-CCUUUUUUUUUGGGGAAAA-3’ 
siC(II) 5’-GUGACCAGCGAAUACCUGU-3’ (siRNA for LacZ )
shPin1 5’-GCCATTTGAAGACGCCTCG-3’ (from siRNA Pin1(I))
shC (II) 5’-GTGACCAGCGAATACCTGT-3’ (from siRNA LacZ) )
for ChIP analysis:
BS1 forward 5’-AAAGTTGAGCCCTGCAAAAA-3’ (677 bp upstream from ATG)
BS1 reverse 5’-AGGCGGGATAGAGCTTATGG-3’; (364 bp upstream from ATG)
BS2 forward 5’-AGAAGGGGTCGGGAGTTTT-3’ (336 bp upstream from ATG)
BS2 reverse 5’-GCTGCCTATTGGCTAGACG-3’ (69 bp upstream from ATG)
Plasmids. N1DE proteins were expressed using pcDNA3-N1DE-Flag and a series of derived 
constructs. It was obtained from human full length Notch1 (pBabe/HA-hNotch1  ) that was 
cloned into EcoRI site of pcDNA3 in frame with a Flag-tag at the C-terminus, then to obtain 
pcDNA3-N1DE a PCR-mediated in-frame deletion of aa 24-1714 was performed. An HA-tag 
was then inserted  at  aa  1731.  pBabe(Puromycin)-N1DE-myc  was generated  starting  from 
pcDNA3-N1DE-Flag  by PCR and subcloning  into  BamHI  and XhoI  digested  pBabe  and 
pcDNA3 (Invitrogen) vectors bearing in frame a myc tag followed by two STOP codons 3’ to 
the XhoI restriction site. pBabe-dP, -d2171, -d2120, -dSTR, -dSTR-dP were gereated by PCR 
starting from pBabe-N1DE-myc. For internal truncations in constructs dSTR and dSTR-dP a 
SalI  restriction  site  at  aa  2175 was  exploited  to  design  one  reverse  annealing  primer  on 
sequence corresponding to aa 2120 and one forward primer starting from that of aa 2175 (both 
containing a SalI restriction site) that were used in combination with the forward and reverse 
primers  of  pBabe-N1DE-myc,  respectively.  After  SalI  restriction  the  PCR  products 
(corresponding to N-terminal to aa 2120 and of aa 2175 to the C-terminal end) were united by 
ligation-mediated PCR using again forward and reverse oligonucleotides of pBabe-N1DE-
myc.  pcDNA3-d2171-myc  was  generated  by  subcloning  from  pBabe-d2171-myc. 
Construction of pcDNA3-d2171-4M-myc started from pcDNA3-d2171-myc by introducing 
sequentially Serine (S) or Threonine (T) to Alanine (A) substitution one after the other by 
site-directed mutagenesis (OligoEngine).  pWZL(Hygromycin)-NdE-Flag was obtained from 
pcDNA3-N1dE-Flag by PCR and subcloning. Retroviral vector pLPC(Puromycin)-HA-Pin1 
was constructed  by  subloning  from  pcDNA3-HA-Pin1.  pcDNA3-HA-Pin1-S67E  was 
obtained  by  site-directed  mutagenesis  from  pcDNA3-HA-Pin1  . pGL3-hPin1/LUC  was 
constructed by subcloning a PCR product containing the human Pin1 promoter from HeLa 
genomic DNA into pGL3 (Promega). All constructs were checked by sequencing.
Plasmid  and  retroviral  vectors. pcDNA3-N1DE-Flag,  pBabe-N1DE-myc  and  deletion 
constructs  for  mapping  studies,  pcDNA3-d2171-myc  and  pcDNA3-d2171-4M  as  well  as 
pWZL-N1DE-Flag, pLPC-HA-Pin1 retroviral expression vectors were generated by standard 
procedures  and  details  appear  in  Supplemental  data.  pBabe-Pin1,  pGL2-HES-1/LUC  and 
pBabe-ER/N1ICD-myc  have  been  described  .  For  RNA  interference,  sequences  of  Pin1 
specific  or  control  siRNA  and  oligonucleotides  for  shDNA cloned  into  pRetro.Super 
(OligoEngine). 
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 Cell  lines  and  treatments.  SKBr-3,  MDA-MB-468,  MDA-MB-435,  MDA-MB-231  and 
MCF-7 are human breast carcinoma cells (MCF-7 were purchased from IZS Brescia, Italy), 
MCF-10A are human normal  immortalized  epithelial  breast  cells,  HEK 293T is  a  human 
embryonic kidney cell line with SV40 large T, H1299 is a human lung carcinoma cell line. 
Immortalized  Pin1-/- fibroblasts  have  been  obtained  by spontaneous  immortalization  from 
Murine Embryo Fibroblasts of C57BL6/129Sv mixed background . All cells were cultured in 
DMEM  (BioWhittakerTM) supplemented  with  10%  Fetal  Bovine  Serum  (Gibco)  and 
Penicillin/Streptomycin, except MCF-10A that were maintained in DMEM:F12 HAM’S (1:2) 
(Sigma) supplemented with 5% Horse Serum (Gibco), 10g/ml Insulin (Sigma), 0.5 g/ml 
Hydrocortisone,  20  ng/ml  EGF  (Peprotech). Transient  transfections  and  luciferase  assays 
were  performed  by  standard  procedures,  as  described  .  For  creation  of  stable  clones  a 
selection corresponding to the expressed vectors was applied for 2 weeks to transfected or 
infected cells at the concentrations of 50  gr/ml for Hygromycin, 2  gr/ml  for Puromycin 
and 0,5mg/ml for Neomycin, respectively. Gamma-secretase Inhibitor DAPT (Sigma), Pin1 
inhibitor PiB (Calbiochem) were dissolved in DMSO and used at a final concentration of 20 
and 0.5  M respectively.  Cycloheximide 50  M (Sigma).  For EDTA treatment, cells were 
washed twice in PBS, then PBS alone or with 5mM EDTA or 5mM EDTA plus GSI was 
added for 15 min, followed by a 15 min chase in culture medium, washed and collected, as 
described. For processing experiments with N1DE deletion constructs, transfected cells were 
split in two parts and treated with either GSI or DMSO. Kinase inhibitors U0126, PD98,059 
(Sigma) and SP600125 (Biosource) were solubilized in DMSO and used at a 10  M final 
concentration for 30 min. Functioning of the inhibitors was tested in Western blot analyses 
using  endogenous  phosphorylated  targets  of  these  kinases  as  markers  (anti-pErk1/2,  Cell 
Signaling, anti-pATF-2, Santa Cruz) (not shown).
Antibodies  for Western blot  and Immunoprecipitation.  The following antibodies  were 
used:  mouse  monoclonal  anti-MPM-2  (Upstate),  rabbit  and  goat  polyclonal  anti-Notch1 
(SantaCruz), rabbit polyclonal anti-N1ICD Val1744 (Cell Signaling), mouse monoclonal anti-
myc  clones  9E10  and  9B11  (Cell  Signaling),  mouse  monoclonal  anti–Flag  and  anti-HA 
(Sigma), rabbit polyclonal  and mouse monoclonal (SantaCruz) anti-Pin1, rabbit polyclonal 
anti-HES-1 .
In  vitro  binding,  immunoprecipitation,  Western blot  and Far  Western.  Pin1 in  vitro 
binding  assays  and Co-IP,  as  well  as  phosphatase  treatment  were  performed  by standard 
procedures, as described . Briefly,  for GST pull-down analysis  using cell  lysates the lysis 
buffer was supplemented with inhibitors of phosphatase (1 mM sodium orthovanadate, 5 mM 
NaF) and protease (phenylmethylsulfonylfluoride (PMSF) 1 mM and chymostatin, leupeptin, 
antipain,  pepstatin  10  g  ml-1 each).  In  case  of  phosphatase  treatment  inhibitors  for 
phosphatase were left out and 400 U ml-1 of lambda phosphatase was added to cell extracts 
and reaction was continued for 2 h at 30°C following the manufacturers’ instructions (New 
England Biolabs) prior to GST pull-down.
For Pin1 immunoprecipitation assays, cells were collected in PBS pH 8.3 buffer (PBS pH 8.3, 
0.1%  Tween-20)  and  lysed  by  passing  through  a  26  G  needle.  For  Notch1 
immunoprecipitations cells were collected in GST pull-down buffer (150 mM NaCl, 50 mM 
Tris/HCl pH 7.5, 10% glycerol, 0.1% Nonidet P-40). Cell lysates were cleared with proteinA 
Sepharose by rocking for 30 min, then Protein A/G sepharose (GE Healthcare) cross-linked 
antibodies, precleared with 10 mg/ml BSA, were added. Binding reactions were left for a 
minimum of  4  hours  to  over  night  rocking  at  4°C.  Then beads  were  washed and bound 
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 proteins  were  loaded  and  separated  in  SDS-Page,  followed  by  Western  blotting  on 
Nitrocellulose membranes (Scleicher & Schuell).
Purified GST-Pin1 protein for Far Western analysis was obtained by immobilization, after 
production  in  bacteria,  on  glutathione  sepharose  4B  beads  (GEhealthcare)  followed  by 
elutions using reduced GSH as a competitor in Tris/HCl pH8 100mM and NaCl 100mM. The 
eluted protein was subsequently purified by dialysis. 
For Far Western Blot analysis proteins were immunoprecipitated with the indicated antibody, 
resolved by SDS Page and blotted onto nitrocellulose membrane. Blocking was perfomed for 
1h at 4°C in PBS plus not fat dry milk 10%. Blots were then incubated with 1µg/ml GST-Pin1 
protein in blocking buffer for 1h. Membranes were washed 4 times in PBS, 0.2% Tween-20. 
Subsequently recognition by standard Western blot was performed. 
Densitometric values of protein levels in Western blot analyses were obtained by Image J 
software.
 
Retroviral  infection.  Ampho/Phoenix  packaging  cells  were  transfected  with  indicated 
retroviral vectors by a standard calcium phosphate method. After 48 h incubation at 32°C, the 
supernatants  containing  viral  particles  were  collected,  and  infection  was  performed  as 
described .
Soft-agar  analysis.  Cells  from SKBr3  and  MCF-10A  stable  clones  used  for  soft  agar 
experiments were resuspended in a top layer of the corresponding culture mediums with 0.3% 
or 0.25% agarose (Gellyphor, Euroclone), respectively, at 10,000 cells per well in triplicate in 
6-well plates and plated on a bottom layer of culture medium containing 1% agarose. Every 2 
days pharmacological treatments (GSI, PIB, DMSO) were repeated.  After three weeks the 
colonies were counted with a 20X objective on a Olympus CK30 microscope. 
RNA extraction and reverse-transcription PCR.  Total  RNA was extracted with TRIzol 
(Invitrogen), and 1 g was reverse-transcribed using SuperscriptIII reverse transcriptase and 
random primers (Invitrogen) following the manufacturer’s instructions. For PCR all primers 
have been chosen or designed in order to anneal on different exons of the respective cDNA 
(HES-1  NM_005524;  Hey1   (or  HERP  2)  AF232239;  Pin1  NM_006221;  GAPDH 
BC083511). 
Chromatin immunoprecipitation (ChIP). Cells were crosslinked with 1% formaldehyde for 
10 min, neutralized with 125 mM glycine pH 2.5 and washed in PBS. Nuclei were prepared 
by hypotonic lysis (5mM Pipes pH 6.8, 85 mM KCl, 0.5% NP40) and centrifugation, and 
resuspended in RIPA-100 buffer (20 mM Tris/HCl, pH 7.5, 100 mM NaCl, 1 mM EDTA, 
0.5% NP40, 0.5% deoxycholate, 0.1% SDS) with protease inhibitor cocktail (Sigma), 1 mM 
PMSF and phosphatase inhibitors (NaF 5 mM, Na3VO4 1 mM). Chromatin was sonicated by 
Bioruptor (Diagenode) to 500-1000 bp average fragment size and cleared by centrifugation. 
IP was performed overnight at 4°C with either 1  g of anti-Notch1 antibody (SC-6014R; 
SantaCruz Biotech.) or as an unrelated control anti-HA-tag antibody (Sigma) at 4 °C. DNA-
protein complexes were recovered by protein A/G PLUS-Agarose (SantaCruz Biotech.) and 
washed sequentially with RIPA-100 and RIPA-250 buffer and LiCl solution (10 mM Tris/HCl 
pH 8, 1 mM EDTA, 250 mM NaCl, 0.5% Na-deoxycholate, 0.5% NP40), then resuspended in 
TE, digested with 2U Dnase-free Rnase (Calbiochem) for 30 min at  37°C, and incubated 
overnight at 68°C with 300 mg/ml Proteinase K (NEB) in 0.5% SDS, 100 mM NaCl to digest 
proteins  and  reverse  crosslinks.  After  purification  by  phenol-chloroform  separation  and 
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 ethanol  precipitation,  DNA  was  resuspended  in  H2O  and  1/10  volume  was  used  for 
quantification. 1/10 of input chromatin was amplified as standard for each experiment. PCR 
products were resolved on 2% agarose gels, visualized by EtBr staining, and quantified with 
Kodak Digital Science 1d 2.0.2 software. Primer sequences are indicated above.
Tissue  Microarray  (TMA)  construction  and  Immunohistochemical  analysis  (IHC). 
Formalin-fixed and paraffin-embedded tissue specimens for TMA construction were obtained 
from Istituto Europeo di Oncologia. TMAs were prepared as described previously . Briefly, 
two representative tumor areas (diameter 0.6 mm) from each sample, identified previously on 
Hematoxylin and Eosin stained sections, were removed from the donor blocks and deposited 
on the recipient  block using a custom-built  precision instrument  (Tissue Arrayer,  Beecher 
Instruments). Serial sections (3 μm) of the resulting recipient block were cut, mounted on 
glass  slides  and  processed  for  immunohistochemistry  with  rabbit  polyclonal  anti-Pin1 
(Calbiochem,  1/200),  rabbit  polyclonal  anti-N1ICD  (Chemicon,  1/750),  and  mouse 
monoclonal  anti-HES-1  (MBL,  Clone  NM1,  1:500)  antibodies.  A  tyramide  signal 
amplification  labeling  kit  (Invitrogen,  TSA  Kit  #21,  Cat#  T20931)  was  used  for  signal 
enhancement of anti-N1ICD and anti-HES-1 immunohistochemical stains. Arbitrary cut offs 
for definition  of  low and high protein expression levels  used for statistical  analysis  were 
established according to both intensity of staining (from 0 to 3) and percentage of stained cells 
(from 0 to 100%) in the tumor nuclei. A semiquantitative score from 0 to 300 was obtained. 
For each gene, cases showing a score below the mean were classified as “low expression” 
whereas cases above the mean as “high expression”. Statistical significant differences were 
assessed according to pearson chi-square.
Statistical analyses. For transfection and processing experiments P-values were obtained by 
applying one-tailed, type 2 t-test (assuming equal variances) using Microsoft Excel. For TMA 
analysis P-values were obtained from pearson chi-square test.
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